Gene Synthesis Market By Type (Custom Gene Synthesis (cDNA, Customized Coding Sequences, Genomic DNA, RNAi (shRNA, siRNA, miRNA), others), Gene Library Synthesis), By Method (Oligo Synthesis (Phosphoramidite Reaction Cycle, High-throughput Array-based gene synthesis Technology), Gene Assembly (Polymerase-Based (Dual-Asymmetric (DA) PCR, Overlap Extension (OE), Polymerase Cycling Assembly, Thermodynamically-Balanced Inside-Out (TBIO), Microchip-based multiplex gene synthesis, Others), Ligase- Based (Shotgun Ligation, Two-Step Ligation and PCR, Ligase Chain Reaction, Brick-based), Recombination-Based (Sequence- and ligation -Independent Cloning (SLIC), Transformation-associated Recombination, BioBrick assembly)), By Components (Software, Service), By Application (Research and Development, Diagnosis, Therapeutics, other applications), By End User (Biotech and Pharmaceuticals Companies, Academic and Research Institutes, Contract Research Organizations) By Region (U.S., Canada, Mexico, Rest of North America, France, UK, Germany, Spain, Italy, Nordic Countries, The Benelux Union, Rest of Europe, China, Japan, India, Australia, New Zealand, Southeast Asia, Rest of Asia Pacific, Saudi Arabia, Kuwait, UAE, Egypt, South Africa, Rest of MEA, Brazil, Rest of Latin America) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2019 – 2027

Report ID :AMI-182 | Category : Healthcare | Published Date : March, 2019 | Pages : 402 | Format :PDF
Buy Now!

Industry Trends

Gene synthesis has revolutionized the field of research in medicine and biology. Since its discovery in 1955, the technology has evolved at a great pace which has enabled researchers and scientists to design and reprogram genomes from scratch. Gene synthesis can be applied for research fields such as healthcare, agriculture and energy to do more experiments, in less time and at a low cost environment. In recent years, this technology has become a building block of synthetic biology as it facilitates synthesis of various types of DNA sequence, including recombinant, mutated, or completely novel DNA sequence without a template.

The most widely used type is synthetic DNA sequence which has its applications in cDNA, genomic DNA, RNA interference and extracellular DNA. Popular techniques such as Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) genome editing, transcription activator-like effectors (TALEs), or any custom DNA constructs are being used for investigational purpose in areas including therapeutic antibodies, protein engineering, neuroscience research, cancer, genetic engineering, vaccine design and plant biology research. Application of gene synthesis in these field has opened up numerous opportunities to develop new products and improve the traditional approaches especially in the field of disease diagnosis and therapeutics.

Researchers in the field of plant biology can improve crop yield and reduced vulnerability to common pest and can also be applied to determine the environmental pollutants in air, soil and water for the increased environmental threats. With such advantageous applications of gene synthesis over the traditional cloning techniques, this technology has proven to be more cost effective. This factor is has aided our global industry in recent past and is anticipated to continue the same trend over the forecast period. However, the field of gene synthesis lacks the skilled workforce for handling the sophisticated techniques which is likely to hinder the market growth.

The global gene synthesis market is anticipated to grow at a CAGR of 27.9% over the forecast period (2019 – 2027).  The study analyzes the market in terms of revenue, across all the major markets.

Global Gene Synthesis Market Revenue, 2019 – 2027

Global Gene Synthesis Market

Competitive Landscape

The report provides both, qualitative and quantitative research of global gene synthesis market, as well as provides worthy insights into the rational scenario and favored development methods adopted by key contenders. The report also offers extensive research on the key players in global gene synthesis market market and detailed insights on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by the major players are also recognized and analyzed in the report. For each company, the report recognizes competitors, product/service type, application and specification, pricing, and gross margin.

Market participants consist of ATDBio Ltd, ATUM, BioCat GmbH, Biomatik, BIONEER CORPORATION, Blue Heron Biotech, LLC, Epoch Life Science Inc, Eurofins Genomics LLC, GENEWIZ, Genscript, Integrated DNA Technologies, Inc, Kaneka Eurogentec S.A., OriGene Technologies, Inc., ProteoGenix, Shanghai Medicilon inc., Synbio Technologies LLC, Thermo Fisher Scientific Inc, Vigene Biosciences Inc among others.

By Type

  • Custom Gene Synthesis
  • cDNA
  • Customized Coding Sequences
  • Genomic DNA
  • RNAi constructs (shRNA, siRNA, miRNA)
  • Others
  • Gene Library Synthesis

By Method

  • Oligo synthesis
    • Phosphoramidite Reaction Cycle
    • High-throughput Array-Based Gene Synthesis Technology
  • Gene assembly
    • Polymerase-Based
      • Dual-Asymmetric (DA) PCR
      • Overlap Extension (OE)
      • Polymerase Cycling Assembly
      • Thermodynamically-Balanced Inside-Out (TBIO)
      • Microchip-based multiplex gene synthesis
      • Others
    • Ligase- Based
      • Shotgun Ligation
      • Two-Step Ligation and PCR
      • Ligase Chain Reaction
      • Brick-based
    • Recombination-Based
      • Sequence- and ligation -Independent Cloning (SLIC)
      • Transformation-associated Recombination
      • BioBrick assembly

By Components

  • Software
  • Services

By Application

  • Research and Development
  • Diagnosis
  • Therapeutics
  • Other applications

By End User

  • Biotech and Pharmaceuticals Companies
  • Academic and Research Institutes
  • Contract Research Organizations

By Geography

  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  •  Latin America

Key Questions

Request Sample

Report Customization

Request for Customization

1.    Market Scope

1.1.   Market Segmentation

1.2.   Years Considered

1.2.1.   Historic Years: 2013 - 2017

1.2.2.   Base Year: 2018

1.2.3.   Forecast Years: 2019 – 2027

2.    Key Target Audiences

3.    Research Methodology

3.1.   Primary Research

3.1.1.   Research Questionnaire

3.1.2.   Global Percentage Breakdown

3.1.3.   Primary Interviews: Key Opinion Leaders (KOLs)

3.2.   Secondary Research

3.2.1.   Paid Databases

3.2.2.   Secondary Sources

3.3.   Market Size Estimates

3.3.1.   Top-Down Approach

3.3.2.   Bottom-Up Approach

3.4.   Data Triangulation Methodology

3.5.   Research Assumptions

4.    Recommendations and Insights from AMI’s Perspective**

5.    Holistic Overview of Gene Synthesis Market

6.    Market Synopsis:  Gene Synthesis Market

7.    Gene Synthesis Market Analysis: Qualitative Perspective

7.1.   Introduction

7.1.1.   Product Definition

7.1.2.   Industry Development

7.2.   Market Dynamics

7.2.1.   Drivers

7.2.2.   Restraints

7.2.3.   Opportunities

7.2.4.   Challenges

7.3.   Trends in Gene Synthesis Market

7.4.   Market Determinants Radar Chart

7.5.   Macro-Economic and Micro-Economic Indicators: Gene Synthesis Market

7.6.   Industry Gross Margin Overview

7.7.   Porter’s Five Force Analysis

7.8.   PESTEL Analysis

7.9.   Value Chain Analysis

7.10. Pricing Analysis, By Region (2018)

7.10.1. North America

7.10.1.1.  U.S

7.10.1.2.  Canada

7.10.1.3.  Mexico

7.10.2. Europe

7.10.2.1.  France

7.10.2.2.  The UK

7.10.2.3.  Spain

7.10.2.4.  Germany

7.10.2.5.  Italy

7.10.2.6.  Nordic Countries

7.10.2.6.1.  Denmark

7.10.2.6.2.  Finland

7.10.2.6.3.  Iceland

7.10.2.6.4.  Sweden

7.10.2.6.5.  Norway

7.10.2.7.  Benelux Union

7.10.2.7.1.  Belgium

7.10.2.7.2.  The Netherlands

7.10.2.7.3.  Luxembourg

7.10.3. Asia Pacific

7.10.3.1.  China

7.10.3.2.  Japan

7.10.3.3.  India

7.10.3.4.  New Zealand

7.10.3.5.  Australia

7.10.3.6.  South Korea

7.10.3.7.  Southeast Asia

7.10.3.7.1.  Indonesia

7.10.3.7.2.  Thailand

7.10.3.7.3.  Malaysia

7.10.3.7.4.  Singapore

7.10.3.7.5.  Rest of South Asia

7.10.4. Middle East and Africa

7.10.4.1.  Saudi Arabia

7.10.4.2.  UAE

7.10.4.3.  Egypt

7.10.4.4.  Kuwait

7.10.4.5.  South Africa

7.10.5. Latin America

7.10.5.1.  Brazil

7.10.5.2.  Argentina

8.    Global Gene Synthesis Market Analysis and Forecasts, 2019 – 2027

8.1.   Overview

8.1.1.   Global Gene Synthesis Market Revenue (US$ Mn)

8.2.   Global Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Type

8.2.1.   Custom Gene Synthesis (Definition, Market Penetration (2018), Market Estimation (2013 – 2018), Market Forecast (2019 – 2027), Compound Annual Growth Rate (CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle East and Africa, Latin America) and Information on cDNA, Customized Coding Sequences, Genomic DNA, RNAi constructs (shRNA, siRNA, miRNA), Others)

8.2.1.1.    cDNA

8.2.1.2.    Customized Coding Sequences

8.2.1.3.    Genomic DNA

8.2.1.4.    RNAi constructs (shRNA, siRNA, miRNA)

8.2.1.5.    Others

8.2.2.   Gene Library Synthesis

8.2.2.1.    Definition

8.2.2.2.    Market Penetration, 2018

8.2.2.3.    Market Estimation, 2013 – 2018

8.2.2.4.    Market Forecast, 2019 – 2027

8.2.2.5.    Compound Annual Growth Rate (CAGR)

8.2.2.6.    Regional Bifurcation

8.2.2.6.1.    North America

8.2.2.6.1.1.  Market Estimation, 2013 – 2018

8.2.2.6.1.2.  Market Forecast, 2019 – 2027

8.2.2.6.2.    Europe

8.2.2.6.2.1.  Market Estimation, 2013 – 2018

8.2.2.6.2.2.  Market Forecast, 2019 – 2027

8.2.2.6.3.    Asia Pacific

8.2.2.6.3.1.  Market Estimation, 2013 – 2018

8.2.2.6.3.2.  Market Forecast, 2019 – 2027

8.2.2.6.4.    Middle East and Africa

8.2.2.6.4.1.  Market Estimation, 2013 – 2018

8.2.2.6.4.2.  Market Forecast, 2019 – 2027

8.2.2.6.5.    Latin America

8.2.2.6.5.1.  Market Estimation, 2013 – 2018

8.2.2.6.5.2.  Market Forecast, 2019 – 2027

8.3.   Key Segment for Channeling Investments

8.3.1.   By Type

9.    Global Gene Synthesis Market Analysis and Forecasts, 2019 – 2027

9.1.   Overview

9.2.   Global Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Method

9.2.1.   Oligo Synthesis (Definition, Market Penetration (2018), Market Estimation (2013 – 2018), Market Forecast (2019 – 2027), Compound Annual Growth Rate (CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle East and Africa, Latin America) and Information on Phosphoramidite Reaction Cycle, High-throughput Array-Based Gene Synthesis Technology)

9.2.1.1.    Phosphoramidite Reaction Cycle

9.2.1.2.    High-throughput Array-Based Gene Synthesis Technology

9.2.2.   Gene assembly (Definition, Market Penetration (2018), Market Estimation (2013 – 2018), Market Forecast (2019 – 2027), Compound Annual Growth Rate (CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle East and Africa, Latin America) and Information on Polymerase-Based, Ligase- Based, Recombination-Based)

9.2.2.1.    Polymerase-Based

9.2.2.1.1.    Dual-Asymmetric (DA) PCR

9.2.2.1.2.    Overlap Extension (OE)

9.2.2.1.3.    Polymerase Cycling Assembly

9.2.2.1.4.    Thermodynamically-Balanced Inside-Out (TBIO)

9.2.2.1.5.    Microchip-based multiplex gene synthesis

9.2.2.1.6.    Others

9.2.2.2.    Ligase- Based

9.2.2.2.1.    Shotgun Ligation

9.2.2.2.2.    Two-Step Ligation and PCR

9.2.2.2.3.    Ligase Chain Reaction

9.2.2.2.4.    Brick-Based

9.2.2.3.    Recombination-Based

9.2.2.3.1.    Sequence- and ligation -Independent Cloning (SLIC)

9.2.2.3.2.    Transformation-associated Recombination

9.2.2.3.3.    BioBrick Assembly

9.3.   Key Segment for Channeling Investments

9.3.1.   By Method

10. Global Gene Synthesis Market Analysis and Forecasts, 2019 – 2027

10.1. Overview

10.2. Global Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Components

10.2.1. Software

10.2.1.1.  Definition

10.2.1.2.  Market Penetration, 2018

10.2.1.3.  Market Estimation, 2013 – 2018

10.2.1.4.  Market Forecast, 2019 – 2027

10.2.1.5.  Compound Annual Growth Rate (CAGR)

10.2.1.6.  Regional Bifurcation

10.2.1.6.1.  North America

10.2.1.6.1.1. Market Estimation, 2013 – 2018

10.2.1.6.1.2. Market Forecast, 2019 – 2027

10.2.1.6.2.  Europe

10.2.1.6.2.1. Market Estimation, 2013 – 2018

10.2.1.6.2.2. Market Forecast, 2019 – 2027

10.2.1.6.3.  Asia Pacific

10.2.1.6.3.1. Market Estimation, 2013 – 2018

10.2.1.6.3.2. Market Forecast, 2019 – 2027

10.2.1.6.4.  Middle East and Africa

10.2.1.6.4.1. Market Estimation, 2013 – 2018

10.2.1.6.4.2. Market Forecast, 2019 – 2027

10.2.1.6.5.  Latin America

10.2.1.6.5.1. Market Estimation, 2013 – 2018

10.2.1.6.5.2. Market Forecast, 2019 – 2027

10.2.2. Services

10.2.2.1.  Definition

10.2.2.2.  Market Penetration, 2018

10.2.2.3.  Market Estimation, 2013 – 2018

10.2.2.4.  Market Forecast, 2019 – 2027

10.2.2.5.  Compound Annual Growth Rate (CAGR)

10.2.2.6.  Regional Bifurcation

10.2.2.6.1.  North America

10.2.2.6.1.1. Market Estimation, 2013 – 2018

10.2.2.6.1.2. Market Forecast, 2019 – 2027

10.2.2.6.2.  Europe

10.2.2.6.2.1. Market Estimation, 2013 – 2018

10.2.2.6.2.2. Market Forecast, 2019 – 2027

10.2.2.6.3.  Asia Pacific

10.2.2.6.3.1. Market Estimation, 2013 – 2018

10.2.2.6.3.2. Market Forecast, 2019 – 2027

10.2.2.6.4.  Middle East and Africa

10.2.2.6.4.1. Market Estimation, 2013 – 2018

10.2.2.6.4.2. Market Forecast, 2019 – 2027

10.2.2.6.5.  Latin America

10.2.2.6.5.1. Market Estimation, 2013 – 2018

10.2.2.6.5.2. Market Forecast, 2019 – 2027

10.3. Key Segment for Channeling Investments

10.3.1. By Components

11. Global Gene Synthesis Market Analysis and Forecasts, 2019 – 2027

11.1. Overview

11.2. Global Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Application

11.2.1. Research and Development

11.2.1.1.  Definition

11.2.1.2.  Market Penetration, 2018

11.2.1.3.  Market Estimation, 2013 – 2018

11.2.1.4.  Market Forecast, 2019 – 2027

11.2.1.5.  Compound Annual Growth Rate (CAGR)

11.2.1.6.  Regional Bifurcation

11.2.1.6.1.  North America

11.2.1.6.1.1. Market Estimation, 2013 – 2018

11.2.1.6.1.2. Market Forecast, 2019 – 2027

11.2.1.6.2.  Europe

11.2.1.6.2.1. Market Estimation, 2013 – 2018

11.2.1.6.2.2. Market Forecast, 2019 – 2027

11.2.1.6.3.  Asia Pacific

11.2.1.6.3.1. Market Estimation, 2013 – 2018

11.2.1.6.3.2. Market Forecast, 2019 – 2027

11.2.1.6.4.  Middle East and Africa

11.2.1.6.4.1. Market Estimation, 2013 – 2018

11.2.1.6.4.2. Market Forecast, 2019 – 2027

11.2.1.6.5.  Latin America

11.2.1.6.5.1. Market Estimation, 2013 – 2018

11.2.1.6.5.2. Market Forecast, 2019 – 2027

11.2.2. Diagnosis

11.2.2.1.  Definition

11.2.2.2.  Market Penetration, 2018

11.2.2.3.  Market Estimation, 2013 – 2018

11.2.2.4.  Market Forecast, 2019 – 2027

11.2.2.5.  Compound Annual Growth Rate (CAGR)

11.2.2.6.  Regional Bifurcation

11.2.2.6.1.  North America

11.2.2.6.1.1. Market Estimation, 2013 – 2018

11.2.2.6.1.2. Market Forecast, 2019 – 2027

11.2.2.6.2.  Europe

11.2.2.6.2.1. Market Estimation, 2013 – 2018

11.2.2.6.2.2. Market Forecast, 2019 – 2027

11.2.2.6.3.  Asia Pacific

11.2.2.6.3.1. Market Estimation, 2013 – 2018

11.2.2.6.3.2. Market Forecast, 2019 – 2027

11.2.2.6.4.  Middle East and Africa

11.2.2.6.4.1. Market Estimation, 2013 – 2018

11.2.2.6.4.2. Market Forecast, 2019 – 2027

11.2.2.6.5.  Latin America

11.2.2.6.5.1. Market Estimation, 2013 – 2018

11.2.2.6.5.2. Market Forecast, 2019 – 2027

11.2.3. Therapeutics

11.2.3.1.  Definition

11.2.3.2.  Market Penetration, 2018

11.2.3.3.  Market Estimation, 2013 – 2018

11.2.3.4.  Market Forecast, 2019 – 2027

11.2.3.5.  Compound Annual Growth Rate (CAGR)

11.2.3.6.  Regional Bifurcation

11.2.3.6.1.  North America

11.2.3.6.1.1. Market Estimation, 2013 – 2018

11.2.3.6.1.2. Market Forecast, 2019 – 2027

11.2.3.6.2.  Europe

11.2.3.6.2.1. Market Estimation, 2013 – 2018

11.2.3.6.2.2. Market Forecast, 2019 – 2027

11.2.3.6.3.  Asia Pacific

11.2.3.6.3.1. Market Estimation, 2013 – 2018

11.2.3.6.3.2. Market Forecast, 2019 – 2027

11.2.3.6.4.  Middle East and Africa

11.2.3.6.4.1. Market Estimation, 2013 – 2018

11.2.3.6.4.2. Market Forecast, 2019 – 2027

11.2.3.6.5.  Latin America

11.2.3.6.5.1. Market Estimation, 2013 – 2018

11.2.3.6.5.2. Market Forecast, 2019 – 2027

11.2.4. Other applications

11.2.4.1.  Definition

11.2.4.2.  Market Penetration, 2018

11.2.4.3.  Market Estimation, 2013 – 2018

11.2.4.4.  Market Forecast, 2019 – 2027

11.2.4.5.  Compound Annual Growth Rate (CAGR)

11.2.4.6.  Regional Bifurcation

11.2.4.6.1.  North America

11.2.4.6.1.1. Market Estimation, 2013 – 2018

11.2.4.6.1.2. Market Forecast, 2019 – 2027

11.2.4.6.2.  Europe

11.2.4.6.2.1. Market Estimation, 2013 – 2018

11.2.4.6.2.2. Market Forecast, 2019 – 2027

11.2.4.6.3.  Asia Pacific

11.2.4.6.3.1. Market Estimation, 2013 – 2018

11.2.4.6.3.2. Market Forecast, 2019 – 2027

11.2.4.6.4.  Middle East and Africa

11.2.4.6.4.1. Market Estimation, 2013 – 2018

11.2.4.6.4.2. Market Forecast, 2019 – 2027

11.2.4.6.5.  Latin America

11.2.4.6.5.1. Market Estimation, 2013 – 2018

11.2.4.6.5.2. Market Forecast, 2019 – 2027

11.3. Key Segment for Channeling Investments

11.3.1. By Application

12. Global Gene Synthesis Market Analysis and Forecasts, 2019 – 2027

12.1. Overview

12.2. Global Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By End User

12.2.1. Biotech and Pharmaceuticals Companies

12.2.1.1.  Definition

12.2.1.2.  Market Penetration, 2018

12.2.1.3.  Market Estimation, 2013 – 2018

12.2.1.4.  Market Forecast, 2019 – 2027

12.2.1.5.  Compound Annual Growth Rate (CAGR)

12.2.1.6.  Regional Bifurcation

12.2.1.6.1.  North America

12.2.1.6.1.1. Market Estimation, 2013 – 2018

12.2.1.6.1.2. Market Forecast, 2019 – 2027

12.2.1.6.2.  Europe

12.2.1.6.2.1. Market Estimation, 2013 – 2018

12.2.1.6.2.2. Market Forecast, 2019 – 2027

12.2.1.6.3.  Asia Pacific

12.2.1.6.3.1. Market Estimation, 2013 – 2018

12.2.1.6.3.2. Market Forecast, 2019 – 2027

12.2.1.6.4.  Middle East and Africa

12.2.1.6.4.1. Market Estimation, 2013 – 2018

12.2.1.6.4.2. Market Forecast, 2019 – 2027

12.2.1.6.5.  Latin America

12.2.1.6.5.1. Market Estimation, 2013 – 2018

12.2.1.6.5.2. Market Forecast, 2019 – 2027

12.2.2. Academic and Research Institutes

12.2.2.1.  Definition

12.2.2.2.  Market Penetration, 2018

12.2.2.3.  Market Estimation, 2013 – 2018

12.2.2.4.  Market Forecast, 2019 – 2027

12.2.2.5.  Compound Annual Growth Rate (CAGR)

12.2.2.6.  Regional Bifurcation

12.2.2.6.1.  North America

12.2.2.6.1.1. Market Estimation, 2013 – 2018

12.2.2.6.1.2. Market Forecast, 2019 – 2027

12.2.2.6.2.  Europe

12.2.2.6.2.1. Market Estimation, 2013 – 2018

12.2.2.6.2.2. Market Forecast, 2019 – 2027

12.2.2.6.3.  Asia Pacific

12.2.2.6.3.1. Market Estimation, 2013 – 2018

12.2.2.6.3.2. Market Forecast, 2019 – 2027

12.2.2.6.4.  Middle East and Africa

12.2.2.6.4.1. Market Estimation, 2013 – 2018

12.2.2.6.4.2. Market Forecast, 2019 – 2027

12.2.2.6.5.  Latin America

12.2.2.6.5.1. Market Estimation, 2013 – 2018

12.2.2.6.5.2. Market Forecast, 2019 – 2027

12.2.3. Contract Research Organizations

12.2.3.1.  Definition

12.2.3.2.  Market Penetration, 2018

12.2.3.3.  Market Estimation, 2013 – 2018

12.2.3.4.  Market Forecast, 2019 – 2027

12.2.3.5.  Compound Annual Growth Rate (CAGR)

12.2.3.6.  Regional Bifurcation

12.2.3.6.1.  North America

12.2.3.6.1.1. Market Estimation, 2013 – 2018

12.2.3.6.1.2. Market Forecast, 2019 – 2027

12.2.3.6.2.  Europe

12.2.3.6.2.1. Market Estimation, 2013 – 2018

12.2.3.6.2.2. Market Forecast, 2019 – 2027

12.2.3.6.3.  Asia Pacific

12.2.3.6.3.1. Market Estimation, 2013 – 2018

12.2.3.6.3.2. Market Forecast, 2019 – 2027

12.2.3.6.4.  Middle East and Africa

12.2.3.6.4.1. Market Estimation, 2013 – 2018

12.2.3.6.4.2. Market Forecast, 2019 – 2027

12.2.3.6.5.  Latin America

12.2.3.6.5.1. Market Estimation, 2013 – 2018

12.2.3.6.5.2. Market Forecast, 2019 – 2027

12.3. Key Segment for Channeling Investments

12.3.1. By End User

13. North America Gene Synthesis Market Analysis and Forecasts, 2019 - 2027

13.1. Overview

13.1.1. North America Gene Synthesis Market Revenue (US$ Mn)

13.2. North America Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Type

13.2.1. Custom Gene Synthesis

13.2.1.1.  cDNA

13.2.1.2.  Customized Coding Sequences

13.2.1.3.  Genomic DNA

13.2.1.4.  RNAi constructs (shRNA, siRNA, miRNA)

13.2.1.5.  Others

13.2.2. Gene Library Synthesis

13.3. North America Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Method

13.3.1. Oligo Synthesis

13.3.1.1.  Phosphoramidite Reaction Cycle

13.3.1.2.  High-throughput Array-Based Gene Synthesis Technology

13.3.2. Gene assembly

13.3.2.1.  Polymerase-Based

13.3.2.1.1.  Dual-Asymmetric (DA) PCR

13.3.2.1.2.  Overlap Extension (OE)

13.3.2.1.3.  Polymerase Cycling Assembly

13.3.2.1.4.  Thermodynamically-Balanced Inside-Out (TBIO)

13.3.2.1.5.  Microchip-based multiplex gene synthesis

13.3.2.1.6.  Others

13.3.2.2.  Ligase- Based

13.3.2.2.1.  Shotgun Ligation

13.3.2.2.2.  Two-Step Ligation and PCR

13.3.2.2.3.  Ligase Chain Reaction

13.3.2.2.4.  Brick-Based

13.3.2.3.  Recombination-Based

13.3.2.3.1.  Sequence- and ligation -Independent Cloning (SLIC)

13.3.2.3.2.  Transformation-associated Recombination

13.3.2.3.3.  BioBrick Assembly

13.4. North America Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Components

13.4.1. Software

13.4.2. Services

13.5. North America Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Application

13.5.1. Research and Development

13.5.2. Diagnosis

13.5.3. Therapeutics

13.5.4. Other applications

13.6. North America Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By End User

13.6.1. Biotech and Pharmaceuticals Companies

13.6.2. Academic and Research Institutes

13.6.3. Contract Research Organizations

13.7. North America Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Country

13.7.1. U.S

13.7.1.1.  U.S Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Type

13.7.1.1.1.  Custom Gene Synthesis

13.7.1.1.1.1. cDNA

13.7.1.1.1.2. Customized Coding Sequences

13.7.1.1.1.3. Genomic DNA

13.7.1.1.1.4. RNAi constructs (shRNA, siRNA, miRNA)

13.7.1.1.1.5. Others

13.7.1.1.2.  Gene Library Synthesis

13.7.1.2.  U.S Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Method

13.7.1.2.1.  Oligo Synthesis

13.7.1.2.1.1. Phosphoramidite Reaction Cycle

13.7.1.2.1.2. High-throughput Array-Based Gene Synthesis Technology

13.7.1.2.2.  Gene assembly

13.7.1.2.2.1. Polymerase-Based

13.7.1.2.2.1.1.  Dual-Asymmetric (DA) PCR

13.7.1.2.2.1.2.  Overlap Extension (OE)

13.7.1.2.2.1.3.  Polymerase Cycling Assembly

13.7.1.2.2.1.4.  Thermodynamically-Balanced Inside-Out (TBIO)

13.7.1.2.2.1.5.  Microchip-based multiplex gene synthesis

13.7.1.2.2.1.6.  Others

13.7.1.2.2.2. Ligase- Based

13.7.1.2.2.2.1.  Shotgun Ligation

13.7.1.2.2.2.2.  Two-Step Ligation and PCR

13.7.1.2.2.2.3.  Ligase Chain Reaction

13.7.1.2.2.2.4.  Brick-Based

13.7.1.2.2.3. Recombination-Based

13.7.1.2.2.3.1.  Sequence- and ligation -Independent Cloning (SLIC)

13.7.1.2.2.3.2.  Transformation-associated Recombination

13.7.1.2.2.3.3.  BioBrick Assembly

13.7.1.3.  U.S Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Components

13.7.1.3.1.  Software

13.7.1.3.2.  Services

13.7.1.4.  U.S Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Application

13.7.1.4.1.  Research and Development

13.7.1.4.2.  Diagnosis

13.7.1.4.3.  Therapeutics

13.7.1.4.4.  Other applications

13.7.1.5.  U.S Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By End User

13.7.1.5.1.  Biotech and Pharmaceuticals Companies

13.7.1.5.2.  Academic and Research Institutes

13.7.1.5.3.  Contract Research Organizations

13.7.2. Canada

13.7.2.1.  Canada Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Type

13.7.2.1.1.  Custom Gene Synthesis

13.7.2.1.1.1. cDNA

13.7.2.1.1.2. Customized Coding Sequences

13.7.2.1.1.3. Genomic DNA

13.7.2.1.1.4. RNAi constructs (shRNA, siRNA, miRNA)

13.7.2.1.1.5. Others

13.7.2.1.2.  Gene Library Synthesis

13.7.2.2.  Canada Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Method

13.7.2.2.1.  Oligo Synthesis

13.7.2.2.1.1. Phosphoramidite Reaction Cycle

13.7.2.2.1.2. High-throughput Array-Based Gene Synthesis Technology

13.7.2.2.2.  Gene assembly

13.7.2.2.2.1. Polymerase-Based

13.7.2.2.2.1.1.  Dual-Asymmetric (DA) PCR

13.7.2.2.2.1.2.  Overlap Extension (OE)

13.7.2.2.2.1.3.  Polymerase Cycling Assembly

13.7.2.2.2.1.4.  Thermodynamically-Balanced Inside-Out (TBIO)

13.7.2.2.2.1.5.  Microchip-based multiplex gene synthesis

13.7.2.2.2.1.6.  Others

13.7.2.2.2.2. Ligase- Based

13.7.2.2.2.2.1.  Shotgun Ligation

13.7.2.2.2.2.2.  Two-Step Ligation and PCR

13.7.2.2.2.2.3.  Ligase Chain Reaction

13.7.2.2.2.2.4.  Brick-Based

13.7.2.2.2.3. Recombination-Based

13.7.2.2.2.3.1.  Sequence- and ligation -Independent Cloning (SLIC)

13.7.2.2.2.3.2.  Transformation-associated Recombination

13.7.2.2.2.3.3.  BioBrick Assembly

13.7.2.3.  Canada Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Components

13.7.2.3.1.  Software

13.7.2.3.2.  Services

13.7.2.4.  Canada Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Application

13.7.2.4.1.  Research and Development

13.7.2.4.2.  Diagnosis

13.7.2.4.3.  Therapeutics

13.7.2.4.4.  Other applications

13.7.2.5.  Canada Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By End User

13.7.2.5.1.  Biotech and Pharmaceuticals Companies

13.7.2.5.2.  Academic and Research Institutes

13.7.2.5.3.  Contract Research Organizations

13.7.3. Mexico

13.7.3.1.  Mexico Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Type

13.7.3.1.1.  Custom Gene Synthesis

13.7.3.1.1.1. cDNA

13.7.3.1.1.2. Customized Coding Sequences

13.7.3.1.1.3. Genomic DNA

13.7.3.1.1.4. RNAi constructs (shRNA, siRNA, miRNA)

13.7.3.1.1.5. Others

13.7.3.1.2.  Gene Library Synthesis

13.7.3.2.  Mexico Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Method

13.7.3.2.1.  Oligo Synthesis

13.7.3.2.1.1. Phosphoramidite Reaction Cycle

13.7.3.2.1.2. High-throughput Array-Based Gene Synthesis Technology

13.7.3.2.2.  Gene assembly

13.7.3.2.2.1. Polymerase-Based

13.7.3.2.2.1.1.  Dual-Asymmetric (DA) PCR

13.7.3.2.2.1.2.  Overlap Extension (OE)

13.7.3.2.2.1.3.  Polymerase Cycling Assembly

13.7.3.2.2.1.4.  Thermodynamically-Balanced Inside-Out (TBIO)

13.7.3.2.2.1.5.  Microchip-based multiplex gene synthesis

13.7.3.2.2.1.6.  Others

13.7.3.2.2.2. Ligase- Based

13.7.3.2.2.2.1.  Shotgun Ligation

13.7.3.2.2.2.2.  Two-Step Ligation and PCR

13.7.3.2.2.2.3.  Ligase Chain Reaction

13.7.3.2.2.2.4.  Brick-Based

13.7.3.2.2.3. Recombination-Based

13.7.3.2.2.3.1.  Sequence- and ligation -Independent Cloning (SLIC)

13.7.3.2.2.3.2.  Transformation-associated Recombination

13.7.3.2.2.3.3.  BioBrick Assembly

13.7.3.3.  Mexico Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Components

13.7.3.3.1.  Software

13.7.3.3.2.  Services

13.7.3.4.  Mexico Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Application

13.7.3.4.1.  Research and Development

13.7.3.4.2.  Diagnosis

13.7.3.4.3.  Therapeutics

13.7.3.4.4.  Other applications

13.7.3.5.  Mexico Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By End User

13.7.3.5.1.  Biotech and Pharmaceuticals Companies

13.7.3.5.2.  Academic and Research Institutes

13.7.3.5.3.  Contract Research Organizations

13.7.4. Rest of North America

13.7.4.1.  Rest of North America Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Type

13.7.4.1.1.  Custom Gene Synthesis

13.7.4.1.1.1. cDNA

13.7.4.1.1.2. Customized Coding Sequences

13.7.4.1.1.3. Genomic DNA

13.7.4.1.1.4. RNAi constructs (shRNA, siRNA, miRNA)

13.7.4.1.1.5. Others

13.7.4.1.2.  Gene Library Synthesis

13.7.4.2.  Rest of North America Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Method

13.7.4.2.1.  Oligo Synthesis

13.7.4.2.1.1. Phosphoramidite Reaction Cycle

13.7.4.2.1.2. High-throughput Array-Based Gene Synthesis Technology

13.7.4.2.2.  Gene assembly

13.7.4.2.2.1. Polymerase-Based

13.7.4.2.2.1.1.  Dual-Asymmetric (DA) PCR

13.7.4.2.2.1.2.  Overlap Extension (OE)

13.7.4.2.2.1.3.  Polymerase Cycling Assembly

13.7.4.2.2.1.4.  Thermodynamically-Balanced Inside-Out (TBIO)

13.7.4.2.2.1.5.  Microchip-based multiplex gene synthesis

13.7.4.2.2.1.6.  Others

13.7.4.2.2.2. Ligase- Based

13.7.4.2.2.2.1.  Shotgun Ligation

13.7.4.2.2.2.2.  Two-Step Ligation and PCR

13.7.4.2.2.2.3.  Ligase Chain Reaction

13.7.4.2.2.2.4.  Brick-Based

13.7.4.2.2.3. Recombination-Based

13.7.4.2.2.3.1.  Sequence- and ligation -Independent Cloning (SLIC)

13.7.4.2.2.3.2.  Transformation-associated Recombination

13.7.4.2.2.3.3.  BioBrick Assembly

13.7.4.3.  Rest of North America Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Components

13.7.4.3.1.  Software

13.7.4.3.2.  Services

13.7.4.4.  Rest of North America Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Application

13.7.4.4.1.  Research and Development

13.7.4.4.2.  Diagnosis

13.7.4.4.3.  Therapeutics

13.7.4.4.4.  Other applications

13.7.4.5.  Rest of North America Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By End User

13.7.4.5.1.  Biotech and Pharmaceuticals Companies

13.7.4.5.2.  Academic and Research Institutes

13.7.4.5.3.  Contract Research Organizations

13.8. Key Segment for Channeling Investments

13.8.1. By Country

13.8.2. By Type

13.8.3. By Method

13.8.4. By Components

13.8.5. By Application

13.8.6. By End User

14. Europe Gene Synthesis Market Analysis and Forecasts, 2019 - 2027

14.1. Overview

14.1.1. Europe Gene Synthesis Market Revenue (US$ Mn)

14.2. Europe Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Type

14.2.1. Custom Gene Synthesis

14.2.1.1.  cDNA

14.2.1.2.  Customized Coding Sequences

14.2.1.3.  Genomic DNA

14.2.1.4.  RNAi constructs (shRNA, siRNA, miRNA)

14.2.1.5.  Others

14.2.2. Gene Library Synthesis

14.3. Europe Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Method

14.3.1. Oligo Synthesis

14.3.1.1.  Phosphoramidite Reaction Cycle

14.3.1.2.  High-throughput Array-Based Gene Synthesis Technology

14.3.2. Gene assembly

14.3.2.1.  Polymerase-Based

14.3.2.1.1.  Dual-Asymmetric (DA) PCR

14.3.2.1.2.  Overlap Extension (OE)

14.3.2.1.3.  Polymerase Cycling Assembly

14.3.2.1.4.  Thermodynamically-Balanced Inside-Out (TBIO)

14.3.2.1.5.  Microchip-based multiplex gene synthesis

14.3.2.1.6.  Others

14.3.2.2.  Ligase- Based

14.3.2.2.1.  Shotgun Ligation

14.3.2.2.2.  Two-Step Ligation and PCR

14.3.2.2.3.  Ligase Chain Reaction

14.3.2.2.4.  Brick-Based

14.3.2.3.  Recombination-Based

14.3.2.3.1.  Sequence- and ligation -Independent Cloning (SLIC)

14.3.2.3.2.  Transformation-associated Recombination

14.3.2.3.3.  BioBrick Assembly

14.4. Europe Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Components

14.4.1. Software

14.4.2. Services

14.5. Europe Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Application

14.5.1. Research and Development

14.5.2. Diagnosis

14.5.3. Therapeutics

14.5.4. Other applications

14.6. Europe Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By End User

14.6.1. Biotech and Pharmaceuticals Companies

14.6.2. Academic and Research Institutes

14.6.3. Contract Research Organizations

14.7. Europe Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Country

14.7.1. France

14.7.1.1.  France Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Type

14.7.1.1.1.  Custom Gene Synthesis

14.7.1.1.1.1. cDNA

14.7.1.1.1.2. Customized Coding Sequences

14.7.1.1.1.3. Genomic DNA

14.7.1.1.1.4. RNAi constructs (shRNA, siRNA, miRNA)

14.7.1.1.1.5. Others

14.7.1.1.2.  Gene Library Synthesis

14.7.1.2.  France Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Method

14.7.1.2.1.  Oligo Synthesis

14.7.1.2.1.1. Phosphoramidite Reaction Cycle

14.7.1.2.1.2. High-throughput Array-Based Gene Synthesis Technology

14.7.1.2.2.  Gene assembly

14.7.1.2.2.1. Polymerase-Based

14.7.1.2.2.1.1.  Dual-Asymmetric (DA) PCR

14.7.1.2.2.1.2.  Overlap Extension (OE)

14.7.1.2.2.1.3.  Polymerase Cycling Assembly

14.7.1.2.2.1.4.  Thermodynamically-Balanced Inside-Out (TBIO)

14.7.1.2.2.1.5.  Microchip-based multiplex gene synthesis

14.7.1.2.2.1.6.  Others

14.7.1.2.2.2. Ligase- Based

14.7.1.2.2.2.1.  Shotgun Ligation

14.7.1.2.2.2.2.  Two-Step Ligation and PCR

14.7.1.2.2.2.3.  Ligase Chain Reaction

14.7.1.2.2.2.4.  Brick-Based

14.7.1.2.2.3. Recombination-Based

14.7.1.2.2.3.1.  Sequence- and ligation -Independent Cloning (SLIC)

14.7.1.2.2.3.2.  Transformation-associated Recombination

14.7.1.2.2.3.3.  BioBrick Assembly

14.7.1.3.  France Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Components

14.7.1.3.1.  Software

14.7.1.3.2.  Services

14.7.1.4.  France Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Application

14.7.1.4.1.  Research and Development

14.7.1.4.2.  Diagnosis

14.7.1.4.3.  Therapeutics

14.7.1.4.4.  Other applications

14.7.1.5.  France Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By End User

14.7.1.5.1.  Biotech and Pharmaceuticals Companies

14.7.1.5.2.  Academic and Research Institutes

14.7.1.5.3.  Contract Research Organizations

14.7.2. The UK

14.7.2.1.  The UK Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Type

14.7.2.1.1.  Custom Gene Synthesis

14.7.2.1.1.1. cDNA

14.7.2.1.1.2. Customized Coding Sequences

14.7.2.1.1.3. Genomic DNA

14.7.2.1.1.4. RNAi constructs (shRNA, siRNA, miRNA)

14.7.2.1.1.5. Others

14.7.2.1.2.  Gene Library Synthesis

14.7.2.2.  The UK Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Method

14.7.2.2.1.  Oligo Synthesis

14.7.2.2.1.1. Phosphoramidite Reaction Cycle

14.7.2.2.1.2. High-throughput Array-Based Gene Synthesis Technology

14.7.2.2.2.  Gene assembly

14.7.2.2.2.1. Polymerase-Based

14.7.2.2.2.1.1.  Dual-Asymmetric (DA) PCR

14.7.2.2.2.1.2.  Overlap Extension (OE)

14.7.2.2.2.1.3.  Polymerase Cycling Assembly

14.7.2.2.2.1.4.  Thermodynamically-Balanced Inside-Out (TBIO)

14.7.2.2.2.1.5.  Microchip-based multiplex gene synthesis

14.7.2.2.2.1.6.  Others

14.7.2.2.2.2. Ligase- Based

14.7.2.2.2.2.1.  Shotgun Ligation

14.7.2.2.2.2.2.  Two-Step Ligation and PCR

14.7.2.2.2.2.3.  Ligase Chain Reaction

14.7.2.2.2.2.4.  Brick-Based

14.7.2.2.2.3. Recombination-Based

14.7.2.2.2.3.1.  Sequence- and ligation -Independent Cloning (SLIC)

14.7.2.2.2.3.2.  Transformation-associated Recombination

14.7.2.2.2.3.3.  BioBrick Assembly

14.7.2.3.  The UK Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Components

14.7.2.3.1.  Software

14.7.2.3.2.  Services

14.7.2.4.  The UK Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Application

14.7.2.4.1.  Research and Development

14.7.2.4.2.  Diagnosis

14.7.2.4.3.  Therapeutics

14.7.2.4.4.  Other applications

14.7.2.5.  The UK Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By End User

14.7.2.5.1.  Biotech and Pharmaceuticals Companies

14.7.2.5.2.  Academic and Research Institutes

14.7.2.5.3.  Contract Research Organizations

14.7.3. Spain

14.7.3.1.  Spain Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Type

14.7.3.1.1.  Custom Gene Synthesis

14.7.3.1.1.1. cDNA

14.7.3.1.1.2. Customized Coding Sequences

14.7.3.1.1.3. Genomic DNA

14.7.3.1.1.4. RNAi constructs (shRNA, siRNA, miRNA)

14.7.3.1.1.5. Others

14.7.3.1.2.  Gene Library Synthesis

14.7.3.2.  Spain Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Method

14.7.3.2.1.  Oligo Synthesis

14.7.3.2.1.1. Phosphoramidite Reaction Cycle

14.7.3.2.1.2. High-throughput Array-Based Gene Synthesis Technology

14.7.3.2.2.  Gene assembly

14.7.3.2.2.1. Polymerase-Based

14.7.3.2.2.1.1.  Dual-Asymmetric (DA) PCR

14.7.3.2.2.1.2.  Overlap Extension (OE)

14.7.3.2.2.1.3.  Polymerase Cycling Assembly

14.7.3.2.2.1.4.  Thermodynamically-Balanced Inside-Out (TBIO)

14.7.3.2.2.1.5.  Microchip-based multiplex gene synthesis

14.7.3.2.2.1.6.  Others

14.7.3.2.2.2. Ligase- Based

14.7.3.2.2.2.1.  Shotgun Ligation

14.7.3.2.2.2.2.  Two-Step Ligation and PCR

14.7.3.2.2.2.3.  Ligase Chain Reaction

14.7.3.2.2.2.4.  Brick-Based

14.7.3.2.2.3. Recombination-Based

14.7.3.2.2.3.1.  Sequence- and ligation -Independent Cloning (SLIC)

14.7.3.2.2.3.2.  Transformation-associated Recombination

14.7.3.2.2.3.3.  BioBrick Assembly

14.7.3.3.  Spain Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Components

14.7.3.3.1.  Software

14.7.3.3.2.  Services

14.7.3.4.  Spain Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Application

14.7.3.4.1.  Research and Development

14.7.3.4.2.  Diagnosis

14.7.3.4.3.  Therapeutics

14.7.3.4.4.  Other applications

14.7.3.5.  Spain Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By End User

14.7.3.5.1.  Biotech and Pharmaceuticals Companies

14.7.3.5.2.  Academic and Research Institutes

14.7.3.5.3.  Contract Research Organizations

14.7.4. Germany

14.7.4.1.  Germany Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Type

14.7.4.1.1.  Custom Gene Synthesis

14.7.4.1.1.1. cDNA

14.7.4.1.1.2. Customized Coding Sequences

14.7.4.1.1.3. Genomic DNA

14.7.4.1.1.4. RNAi constructs (shRNA, siRNA, miRNA)

14.7.4.1.1.5. Others

14.7.4.1.2.  Gene Library Synthesis

14.7.4.2.  Germany Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Method

14.7.4.2.1.  Oligo Synthesis

14.7.4.2.1.1. Phosphoramidite Reaction Cycle

14.7.4.2.1.2. High-throughput Array-Based Gene Synthesis Technology

14.7.4.2.2.  Gene assembly

14.7.4.2.2.1. Polymerase-Based

14.7.4.2.2.1.1.  Dual-Asymmetric (DA) PCR

14.7.4.2.2.1.2.  Overlap Extension (OE)

14.7.4.2.2.1.3.  Polymerase Cycling Assembly

14.7.4.2.2.1.4.  Thermodynamically-Balanced Inside-Out (TBIO)

14.7.4.2.2.1.5.  Microchip-based multiplex gene synthesis

14.7.4.2.2.1.6.  Others

14.7.4.2.2.2. Ligase- Based

14.7.4.2.2.2.1.  Shotgun Ligation

14.7.4.2.2.2.2.  Two-Step Ligation and PCR

14.7.4.2.2.2.3.  Ligase Chain Reaction

14.7.4.2.2.2.4.  Brick-Based

14.7.4.2.2.3. Recombination-Based

14.7.4.2.2.3.1.  Sequence- and ligation -Independent Cloning (SLIC)

14.7.4.2.2.3.2.  Transformation-associated Recombination

14.7.4.2.2.3.3.  BioBrick Assembly

14.7.4.3.  Germany Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Components

14.7.4.3.1.  Software

14.7.4.3.2.  Services

14.7.4.4.  Germany Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Application

14.7.4.4.1.  Research and Development

14.7.4.4.2.  Diagnosis

14.7.4.4.3.  Therapeutics

14.7.4.4.4.  Other applications

14.7.4.5.  Germany Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By End User

14.7.4.5.1.  Biotech and Pharmaceuticals Companies

14.7.4.5.2.  Academic and Research Institutes

14.7.4.5.3.  Contract Research Organizations

14.7.5. Italy

14.7.5.1.  Italy Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Type

14.7.5.1.1.  Custom Gene Synthesis

14.7.5.1.1.1. cDNA

14.7.5.1.1.2. Customized Coding Sequences

14.7.5.1.1.3. Genomic DNA

14.7.5.1.1.4. RNAi constructs (shRNA, siRNA, miRNA)

14.7.5.1.1.5. Others

14.7.5.1.2.  Gene Library Synthesis

14.7.5.2.  Italy Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Method

14.7.5.2.1.  Oligo Synthesis

14.7.5.2.1.1. Phosphoramidite Reaction Cycle

14.7.5.2.1.2. High-throughput Array-Based Gene Synthesis Technology

14.7.5.2.2.  Gene assembly

14.7.5.2.2.1. Polymerase-Based

14.7.5.2.2.1.1.  Dual-Asymmetric (DA) PCR

14.7.5.2.2.1.2.  Overlap Extension (OE)

14.7.5.2.2.1.3.  Polymerase Cycling Assembly

14.7.5.2.2.1.4.  Thermodynamically-Balanced Inside-Out (TBIO)

14.7.5.2.2.1.5.  Microchip-based multiplex gene synthesis

14.7.5.2.2.1.6.  Others

14.7.5.2.2.2. Ligase- Based

14.7.5.2.2.2.1.  Shotgun Ligation

14.7.5.2.2.2.2.  Two-Step Ligation and PCR

14.7.5.2.2.2.3.  Ligase Chain Reaction

14.7.5.2.2.2.4.  Brick-Based

14.7.5.2.2.3. Recombination-Based

14.7.5.2.2.3.1.  Sequence- and ligation -Independent Cloning (SLIC)

14.7.5.2.2.3.2.  Transformation-associated Recombination

14.7.5.2.2.3.3.  BioBrick Assembly

14.7.5.3.  Italy Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Components

14.7.5.3.1.  Software

14.7.5.3.2.  Services

14.7.5.4.  Italy Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Application

14.7.5.4.1.  Research and Development

14.7.5.4.2.  Diagnosis

14.7.5.4.3.  Therapeutics

14.7.5.4.4.  Other applications

14.7.5.5.  Italy Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By End User

14.7.5.5.1.  Biotech and Pharmaceuticals Companies

14.7.5.5.2.  Academic and Research Institutes

14.7.5.5.3.  Contract Research Organizations

14.7.6. Nordic Countries

14.7.6.1.  Nordic Countries Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Type

14.7.6.1.1.  Custom Gene Synthesis

14.7.6.1.1.1. cDNA

14.7.6.1.1.2. Customized Coding Sequences

14.7.6.1.1.3. Genomic DNA

14.7.6.1.1.4. RNAi constructs (shRNA, siRNA, miRNA)

14.7.6.1.1.5. Others

14.7.6.1.2.  Gene Library Synthesis

14.7.6.2.  Nordic Countries Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Method

14.7.6.2.1.  Oligo Synthesis

14.7.6.2.1.1. Phosphoramidite Reaction Cycle

14.7.6.2.1.2. High-throughput Array-Based Gene Synthesis Technology

14.7.6.2.2.  Gene assembly

14.7.6.2.2.1. Polymerase-Based

14.7.6.2.2.1.1.  Dual-Asymmetric (DA) PCR

14.7.6.2.2.1.2.  Overlap Extension (OE)

14.7.6.2.2.1.3.  Polymerase Cycling Assembly

14.7.6.2.2.1.4.  Thermodynamically-Balanced Inside-Out (TBIO)

14.7.6.2.2.1.5.  Microchip-based multiplex gene synthesis

14.7.6.2.2.1.6.  Others

14.7.6.2.2.2. Ligase- Based

14.7.6.2.2.2.1.  Shotgun Ligation

14.7.6.2.2.2.2.  Two-Step Ligation and PCR

14.7.6.2.2.2.3.  Ligase Chain Reaction

14.7.6.2.2.2.4.  Brick-Based

14.7.6.2.2.3. Recombination-Based

14.7.6.2.2.3.1.  Sequence- and ligation -Independent Cloning (SLIC)

14.7.6.2.2.3.2.  Transformation-associated Recombination

14.7.6.2.2.3.3.  BioBrick Assembly

14.7.6.3.  Nordic Countries Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Components

14.7.6.3.1.  Software

14.7.6.3.2.  Services

14.7.6.4.  Nordic Countries Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Application

14.7.6.4.1.  Research and Development

14.7.6.4.2.  Diagnosis

14.7.6.4.3.  Therapeutics

14.7.6.4.4.  Other applications

14.7.6.5.  Nordic Countries Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By End User

14.7.6.5.1.  Biotech and Pharmaceuticals Companies

14.7.6.5.2.  Academic and Research Institutes

14.7.6.5.3.  Contract Research Organizations

14.7.6.6.  Nordic Countries Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Country

14.7.6.6.1.  Denmark

14.7.6.6.2.  Finland

14.7.6.6.3.  Iceland

14.7.6.6.4.  Sweden

14.7.6.6.5.  Norway

14.7.7. Benelux Union

14.7.7.1.  Benelux Union Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Type

14.7.7.1.1.  Custom Gene Synthesis

14.7.7.1.1.1. cDNA

14.7.7.1.1.2. Customized Coding Sequences

14.7.7.1.1.3. Genomic DNA

14.7.7.1.1.4. RNAi constructs (shRNA, siRNA, miRNA)

14.7.7.1.1.5. Others

14.7.7.1.2.  Gene Library Synthesis

14.7.7.2.  Benelux Union Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Method

14.7.7.2.1.  Oligo Synthesis

14.7.7.2.1.1. Phosphoramidite Reaction Cycle

14.7.7.2.1.2. High-throughput Array-Based Gene Synthesis Technology

14.7.7.2.2.  Gene assembly

14.7.7.2.2.1. Polymerase-Based

14.7.7.2.2.1.1.  Dual-Asymmetric (DA) PCR

14.7.7.2.2.1.2.  Overlap Extension (OE)

14.7.7.2.2.1.3.  Polymerase Cycling Assembly

14.7.7.2.2.1.4.  Thermodynamically-Balanced Inside-Out (TBIO)

14.7.7.2.2.1.5.  Microchip-based multiplex gene synthesis

14.7.7.2.2.1.6.  Others

14.7.7.2.2.2. Ligase- Based

14.7.7.2.2.2.1.  Shotgun Ligation

14.7.7.2.2.2.2.  Two-Step Ligation and PCR

14.7.7.2.2.2.3.  Ligase Chain Reaction

14.7.7.2.2.2.4.  Brick-Based

14.7.7.2.2.3. Recombination-Based

14.7.7.2.2.3.1.  Sequence- and ligation -Independent Cloning (SLIC)

14.7.7.2.2.3.2.  Transformation-associated Recombination

14.7.7.2.2.3.3.  BioBrick Assembly

14.7.7.3.  Benelux Union Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Components

14.7.7.3.1.  Software

14.7.7.3.2.  Services

14.7.7.4.  Benelux Union Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Application

14.7.7.4.1.  Research and Development

14.7.7.4.2.  Diagnosis

14.7.7.4.3.  Therapeutics

14.7.7.4.4.  Other applications

14.7.7.5.  Benelux Union Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By End User

14.7.7.5.1.  Biotech and Pharmaceuticals Companies

14.7.7.5.2.  Academic and Research Institutes

14.7.7.5.3.  Contract Research Organizations

14.7.7.6.  Benelux Union Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Country

14.7.7.6.1.  Belgium

14.7.7.6.2.  The Netherlands

14.7.7.6.3.  Luxembourg

14.7.8. Rest of Europe

14.7.8.1.  Rest of Europe Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Type

14.7.8.1.1.  Custom Gene Synthesis

14.7.8.1.1.1. cDNA

14.7.8.1.1.2. Customized Coding Sequences

14.7.8.1.1.3. Genomic DNA

14.7.8.1.1.4. RNAi constructs (shRNA, siRNA, miRNA)

14.7.8.1.1.5. Others

14.7.8.1.2.  Gene Library Synthesis

14.7.8.2.  Rest of Europe Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Method

14.7.8.2.1.  Oligo Synthesis

14.7.8.2.1.1. Phosphoramidite Reaction Cycle

14.7.8.2.1.2. High-throughput Array-Based Gene Synthesis Technology

14.7.8.2.2.  Gene assembly

14.7.8.2.2.1. Polymerase-Based

14.7.8.2.2.1.1.  Dual-Asymmetric (DA) PCR

14.7.8.2.2.1.2.  Overlap Extension (OE)

14.7.8.2.2.1.3.  Polymerase Cycling Assembly

14.7.8.2.2.1.4.  Thermodynamically-Balanced Inside-Out (TBIO)

14.7.8.2.2.1.5.  Microchip-based multiplex gene synthesis

14.7.8.2.2.1.6.  Others

14.7.8.2.2.2. Ligase- Based

14.7.8.2.2.2.1.  Shotgun Ligation

14.7.8.2.2.2.2.  Two-Step Ligation and PCR

14.7.8.2.2.2.3.  Ligase Chain Reaction

14.7.8.2.2.2.4.  Brick-Based

14.7.8.2.2.3. Recombination-Based

14.7.8.2.2.3.1.  Sequence- and ligation -Independent Cloning (SLIC)

14.7.8.2.2.3.2.  Transformation-associated Recombination

14.7.8.2.2.3.3.  BioBrick Assembly

14.7.8.3.  Rest of Europe Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Components

14.7.8.3.1.  Software

14.7.8.3.2.  Services

14.7.8.4.  Rest of Europe Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Application

14.7.8.4.1.  Research and Development

14.7.8.4.2.  Diagnosis

14.7.8.4.3.  Therapeutics

14.7.8.4.4.  Other applications

14.7.8.5.  Rest of Europe Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By End User

14.7.8.5.1.  Biotech and Pharmaceuticals Companies

14.7.8.5.2.  Academic and Research Institutes

14.7.8.5.3.  Contract Research Organizations

14.8. Key Segment for Channeling Investments

14.8.1. By Country

14.8.2. By Type

14.8.3. By Method

14.8.4. By Components

14.8.5. By Application

14.8.6. By End User

15. Asia Pacific Gene Synthesis Market Analysis and Forecasts, 2019 - 2027

15.1. Overview

15.1.1. Asia Pacific Gene Synthesis Market Revenue (US$ Mn)

15.2. Asia Pacific Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Type

15.2.1. Custom Gene Synthesis

15.2.1.1.  cDNA

15.2.1.2.  Customized Coding Sequences

15.2.1.3.  Genomic DNA

15.2.1.4.  RNAi constructs (shRNA, siRNA, miRNA)

15.2.1.5.  Others

15.2.2. Gene Library Synthesis

15.3. Asia Pacific Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Method

15.3.1. Oligo Synthesis

15.3.1.1.  Phosphoramidite Reaction Cycle

15.3.1.2.  High-throughput Array-Based Gene Synthesis Technology

15.3.2. Gene assembly

15.3.2.1.  Polymerase-Based

15.3.2.1.1.  Dual-Asymmetric (DA) PCR

15.3.2.1.2.  Overlap Extension (OE)

15.3.2.1.3.  Polymerase Cycling Assembly

15.3.2.1.4.  Thermodynamically-Balanced Inside-Out (TBIO)

15.3.2.1.5.  Microchip-based multiplex gene synthesis

15.3.2.1.6.  Others

15.3.2.2.  Ligase- Based

15.3.2.2.1.  Shotgun Ligation

15.3.2.2.2.  Two-Step Ligation and PCR

15.3.2.2.3.  Ligase Chain Reaction

15.3.2.2.4.  Brick-Based

15.3.2.3.  Recombination-Based

15.3.2.3.1.  Sequence- and ligation -Independent Cloning (SLIC)

15.3.2.3.2.  Transformation-associated Recombination

15.3.2.3.3.  BioBrick Assembly

15.4. Asia Pacific Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Components

15.4.1. Software

15.4.2. Services

15.5. Asia Pacific Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Application

15.5.1. Research and Development

15.5.2. Diagnosis

15.5.3. Therapeutics

15.5.4. Other applications

15.6. Asia Pacific Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By End User

15.6.1. Biotech and Pharmaceuticals Companies

15.6.2. Academic and Research Institutes

15.6.3. Contract Research Organizations

15.7. Asia Pacific Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Country

15.7.1. China

15.7.1.1.  China Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Type

15.7.1.1.1.  Custom Gene Synthesis

15.7.1.1.1.1. cDNA

15.7.1.1.1.2. Customized Coding Sequences

15.7.1.1.1.3. Genomic DNA

15.7.1.1.1.4. RNAi constructs (shRNA, siRNA, miRNA)

15.7.1.1.1.5. Others

15.7.1.1.2.  Gene Library Synthesis

15.7.1.2.  China Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Method

15.7.1.2.1.  Oligo Synthesis

15.7.1.2.1.1. Phosphoramidite Reaction Cycle

15.7.1.2.1.2. High-throughput Array-Based Gene Synthesis Technology

15.7.1.2.2.  Gene assembly

15.7.1.2.2.1. Polymerase-Based

15.7.1.2.2.1.1.  Dual-Asymmetric (DA) PCR

15.7.1.2.2.1.2.  Overlap Extension (OE)

15.7.1.2.2.1.3.  Polymerase Cycling Assembly

15.7.1.2.2.1.4.  Thermodynamically-Balanced Inside-Out (TBIO)

15.7.1.2.2.1.5.  Microchip-based multiplex gene synthesis

15.7.1.2.2.1.6.  Others

15.7.1.2.2.2. Ligase- Based

15.7.1.2.2.2.1.  Shotgun Ligation

15.7.1.2.2.2.2.  Two-Step Ligation and PCR

15.7.1.2.2.2.3.  Ligase Chain Reaction

15.7.1.2.2.2.4.  Brick-Based

15.7.1.2.2.3. Recombination-Based

15.7.1.2.2.3.1.  Sequence- and ligation -Independent Cloning (SLIC)

15.7.1.2.2.3.2.  Transformation-associated Recombination

15.7.1.2.2.3.3.  BioBrick Assembly

15.7.1.3.  China Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Components

15.7.1.3.1.  Software

15.7.1.3.2.  Services

15.7.1.4.  China Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Application

15.7.1.4.1.  Research and Development

15.7.1.4.2.  Diagnosis

15.7.1.4.3.  Therapeutics

15.7.1.4.4.  Other applications

15.7.1.5.  China Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By End User

15.7.1.5.1.  Biotech and Pharmaceuticals Companies

15.7.1.5.2.  Academic and Research Institutes

15.7.1.5.3.  Contract Research Organizations

15.7.2. Japan

15.7.2.1.  Japan Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Type

15.7.2.1.1.  Custom Gene Synthesis

15.7.2.1.1.1. cDNA

15.7.2.1.1.2. Customized Coding Sequences

15.7.2.1.1.3. Genomic DNA

15.7.2.1.1.4. RNAi constructs (shRNA, siRNA, miRNA)

15.7.2.1.1.5. Others

15.7.2.1.2.  Gene Library Synthesis

15.7.2.2.  Japan Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Method

15.7.2.2.1.  Oligo Synthesis

15.7.2.2.1.1. Phosphoramidite Reaction Cycle

15.7.2.2.1.2. High-throughput Array-Based Gene Synthesis Technology

15.7.2.2.2.  Gene assembly

15.7.2.2.2.1. Polymerase-Based

15.7.2.2.2.1.1.  Dual-Asymmetric (DA) PCR

15.7.2.2.2.1.2.  Overlap Extension (OE)

15.7.2.2.2.1.3.  Polymerase Cycling Assembly

15.7.2.2.2.1.4.  Thermodynamically-Balanced Inside-Out (TBIO)

15.7.2.2.2.1.5.  Microchip-based multiplex gene synthesis

15.7.2.2.2.1.6.  Others

15.7.2.2.2.2. Ligase- Based

15.7.2.2.2.2.1.  Shotgun Ligation

15.7.2.2.2.2.2.  Two-Step Ligation and PCR

15.7.2.2.2.2.3.  Ligase Chain Reaction

15.7.2.2.2.2.4.  Brick-Based

15.7.2.2.2.3. Recombination-Based

15.7.2.2.2.3.1.  Sequence- and ligation -Independent Cloning (SLIC)

15.7.2.2.2.3.2.  Transformation-associated Recombination

15.7.2.2.2.3.3.  BioBrick Assembly

15.7.2.3.  Japan Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Components

15.7.2.3.1.  Software

15.7.2.3.2.  Services

15.7.2.4.  Japan Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Application

15.7.2.4.1.  Research and Development

15.7.2.4.2.  Diagnosis

15.7.2.4.3.  Therapeutics

15.7.2.4.4.  Other applications

15.7.2.5.  Japan Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By End User

15.7.2.5.1.  Biotech and Pharmaceuticals Companies

15.7.2.5.2.  Academic and Research Institutes

15.7.2.5.3.  Contract Research Organizations

15.7.3. India

15.7.3.1.  India Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Type

15.7.3.1.1.  Custom Gene Synthesis

15.7.3.1.1.1. cDNA

15.7.3.1.1.2. Customized Coding Sequences

15.7.3.1.1.3. Genomic DNA

15.7.3.1.1.4. RNAi constructs (shRNA, siRNA, miRNA)

15.7.3.1.1.5. Others

15.7.3.1.2.  Gene Library Synthesis

15.7.3.2.  India Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Method

15.7.3.2.1.  Oligo Synthesis

15.7.3.2.1.1. Phosphoramidite Reaction Cycle

15.7.3.2.1.2. High-throughput Array-Based Gene Synthesis Technology

15.7.3.2.2.  Gene assembly

15.7.3.2.2.1. Polymerase-Based

15.7.3.2.2.1.1.  Dual-Asymmetric (DA) PCR

15.7.3.2.2.1.2.  Overlap Extension (OE)

15.7.3.2.2.1.3.  Polymerase Cycling Assembly

15.7.3.2.2.1.4.  Thermodynamically-Balanced Inside-Out (TBIO)

15.7.3.2.2.1.5.  Microchip-based multiplex gene synthesis

15.7.3.2.2.1.6.  Others

15.7.3.2.2.2. Ligase- Based

15.7.3.2.2.2.1.  Shotgun Ligation

15.7.3.2.2.2.2.  Two-Step Ligation and PCR

15.7.3.2.2.2.3.  Ligase Chain Reaction

15.7.3.2.2.2.4.  Brick-Based

15.7.3.2.2.3. Recombination-Based

15.7.3.2.2.3.1.  Sequence- and ligation -Independent Cloning (SLIC)

15.7.3.2.2.3.2.  Transformation-associated Recombination

15.7.3.2.2.3.3.  BioBrick Assembly

15.7.3.3.  India Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Components

15.7.3.3.1.  Software

15.7.3.3.2.  Services

15.7.3.4.  India Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Application

15.7.3.4.1.  Research and Development

15.7.3.4.2.  Diagnosis

15.7.3.4.3.  Therapeutics

15.7.3.4.4.  Other applications

15.7.3.5.  India Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By End User

15.7.3.5.1.  Biotech and Pharmaceuticals Companies

15.7.3.5.2.  Academic and Research Institutes

15.7.3.5.3.  Contract Research Organizations

15.7.4. New Zealand

15.7.4.1.  New Zealand Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Type

15.7.4.1.1.  Custom Gene Synthesis

15.7.4.1.1.1. cDNA

15.7.4.1.1.2. Customized Coding Sequences

15.7.4.1.1.3. Genomic DNA

15.7.4.1.1.4. RNAi constructs (shRNA, siRNA, miRNA)

15.7.4.1.1.5. Others

15.7.4.1.2.  Gene Library Synthesis

15.7.4.2.  New Zealand Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Method

15.7.4.2.1.  Oligo Synthesis

15.7.4.2.1.1. Phosphoramidite Reaction Cycle

15.7.4.2.1.2. High-throughput Array-Based Gene Synthesis Technology

15.7.4.2.2.  Gene assembly

15.7.4.2.2.1. Polymerase-Based

15.7.4.2.2.1.1.  Dual-Asymmetric (DA) PCR

15.7.4.2.2.1.2.  Overlap Extension (OE)

15.7.4.2.2.1.3.  Polymerase Cycling Assembly

15.7.4.2.2.1.4.  Thermodynamically-Balanced Inside-Out (TBIO)

15.7.4.2.2.1.5.  Microchip-based multiplex gene synthesis

15.7.4.2.2.1.6.  Others

15.7.4.2.2.2. Ligase- Based

15.7.4.2.2.2.1.  Shotgun Ligation

15.7.4.2.2.2.2.  Two-Step Ligation and PCR

15.7.4.2.2.2.3.  Ligase Chain Reaction

15.7.4.2.2.2.4.  Brick-Based

15.7.4.2.2.3. Recombination-Based

15.7.4.2.2.3.1.  Sequence- and ligation -Independent Cloning (SLIC)

15.7.4.2.2.3.2.  Transformation-associated Recombination

15.7.4.2.2.3.3.  BioBrick Assembly

15.7.4.3.  New Zealand Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Components

15.7.4.3.1.  Software

15.7.4.3.2.  Services

15.7.4.4.  New Zealand Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Application

15.7.4.4.1.  Research and Development

15.7.4.4.2.  Diagnosis

15.7.4.4.3.  Therapeutics

15.7.4.4.4.  Other applications

15.7.4.5.  New Zealand Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By End User

15.7.4.5.1.  Biotech and Pharmaceuticals Companies

15.7.4.5.2.  Academic and Research Institutes

15.7.4.5.3.  Contract Research Organizations

15.7.5. Australia

15.7.5.1.  Australia Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Type

15.7.5.1.1.  Custom Gene Synthesis

15.7.5.1.1.1. cDNA

15.7.5.1.1.2. Customized Coding Sequences

15.7.5.1.1.3. Genomic DNA

15.7.5.1.1.4. RNAi constructs (shRNA, siRNA, miRNA)

15.7.5.1.1.5. Others

15.7.5.1.2.  Gene Library Synthesis

15.7.5.2.  Australia Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Method

15.7.5.2.1.  Oligo Synthesis

15.7.5.2.1.1. Phosphoramidite Reaction Cycle

15.7.5.2.1.2. High-throughput Array-Based Gene Synthesis Technology

15.7.5.2.2.  Gene assembly

15.7.5.2.2.1. Polymerase-Based

15.7.5.2.2.1.1.  Dual-Asymmetric (DA) PCR

15.7.5.2.2.1.2.  Overlap Extension (OE)

15.7.5.2.2.1.3.  Polymerase Cycling Assembly

15.7.5.2.2.1.4.  Thermodynamically-Balanced Inside-Out (TBIO)

15.7.5.2.2.1.5.  Microchip-based multiplex gene synthesis

15.7.5.2.2.1.6.  Others

15.7.5.2.2.2. Ligase- Based

15.7.5.2.2.2.1.  Shotgun Ligation

15.7.5.2.2.2.2.  Two-Step Ligation and PCR

15.7.5.2.2.2.3.  Ligase Chain Reaction

15.7.5.2.2.2.4.  Brick-Based

15.7.5.2.2.3. Recombination-Based

15.7.5.2.2.3.1.  Sequence- and ligation -Independent Cloning (SLIC)

15.7.5.2.2.3.2.  Transformation-associated Recombination

15.7.5.2.2.3.3.  BioBrick Assembly

15.7.5.3.  Australia Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Components

15.7.5.3.1.  Software

15.7.5.3.2.  Services

15.7.5.4.  Australia Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Application

15.7.5.4.1.  Research and Development

15.7.5.4.2.  Diagnosis

15.7.5.4.3.  Therapeutics

15.7.5.4.4.  Other applications

15.7.5.5.  Australia Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By End User

15.7.5.5.1.  Biotech and Pharmaceuticals Companies

15.7.5.5.2.  Academic and Research Institutes

15.7.5.5.3.  Contract Research Organizations

15.7.6. South Korea

15.7.6.1.  South Korea Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Type

15.7.6.1.1.  Custom Gene Synthesis

15.7.6.1.1.1. cDNA

15.7.6.1.1.2. Customized Coding Sequences

15.7.6.1.1.3. Genomic DNA

15.7.6.1.1.4. RNAi constructs (shRNA, siRNA, miRNA)

15.7.6.1.1.5. Others

15.7.6.1.2.  Gene Library Synthesis

15.7.6.2.  South Korea Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Method

15.7.6.2.1.  Oligo Synthesis

15.7.6.2.1.1. Phosphoramidite Reaction Cycle

15.7.6.2.1.2. High-throughput Array-Based Gene Synthesis Technology

15.7.6.2.2.  Gene assembly

15.7.6.2.2.1. Polymerase-Based

15.7.6.2.2.1.1.  Dual-Asymmetric (DA) PCR

15.7.6.2.2.1.2.  Overlap Extension (OE)

15.7.6.2.2.1.3.  Polymerase Cycling Assembly

15.7.6.2.2.1.4.  Thermodynamically-Balanced Inside-Out (TBIO)

15.7.6.2.2.1.5.  Microchip-based multiplex gene synthesis

15.7.6.2.2.1.6.  Others

15.7.6.2.2.2. Ligase- Based

15.7.6.2.2.2.1.  Shotgun Ligation

15.7.6.2.2.2.2.  Two-Step Ligation and PCR

15.7.6.2.2.2.3.  Ligase Chain Reaction

15.7.6.2.2.2.4.  Brick-Based

15.7.6.2.2.3. Recombination-Based

15.7.6.2.2.3.1.  Sequence- and ligation -Independent Cloning (SLIC)

15.7.6.2.2.3.2.  Transformation-associated Recombination

15.7.6.2.2.3.3.  BioBrick Assembly

15.7.6.3.  South Korea Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Components

15.7.6.3.1.  Software

15.7.6.3.2.  Services

15.7.6.4.  South Korea Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Application

15.7.6.4.1.  Research and Development

15.7.6.4.2.  Diagnosis

15.7.6.4.3.  Therapeutics

15.7.6.4.4.  Other applications

15.7.6.5.  South Korea Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By End User

15.7.6.5.1.  Biotech and Pharmaceuticals Companies

15.7.6.5.2.  Academic and Research Institutes

15.7.6.5.3.  Contract Research Organizations

15.7.7. Southeast Asia

15.7.7.1.  Southeast Asia Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Type

15.7.7.1.1.  Custom Gene Synthesis

15.7.7.1.1.1. cDNA

15.7.7.1.1.2. Customized Coding Sequences

15.7.7.1.1.3. Genomic DNA

15.7.7.1.1.4. RNAi constructs (shRNA, siRNA, miRNA)

15.7.7.1.1.5. Others

15.7.7.1.2.  Gene Library Synthesis

15.7.7.2.  Southeast Asia Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Method

15.7.7.2.1.  Oligo Synthesis

15.7.7.2.1.1. Phosphoramidite Reaction Cycle

15.7.7.2.1.2. High-throughput Array-Based Gene Synthesis Technology

15.7.7.2.2.  Gene assembly

15.7.7.2.2.1. Polymerase-Based

15.7.7.2.2.1.1.  Dual-Asymmetric (DA) PCR

15.7.7.2.2.1.2.  Overlap Extension (OE)

15.7.7.2.2.1.3.  Polymerase Cycling Assembly

15.7.7.2.2.1.4.  Thermodynamically-Balanced Inside-Out (TBIO)

15.7.7.2.2.1.5.  Microchip-based multiplex gene synthesis

15.7.7.2.2.1.6.  Others

15.7.7.2.2.2. Ligase- Based

15.7.7.2.2.2.1.  Shotgun Ligation

15.7.7.2.2.2.2.  Two-Step Ligation and PCR

15.7.7.2.2.2.3.  Ligase Chain Reaction

15.7.7.2.2.2.4.  Brick-Based

15.7.7.2.2.3. Recombination-Based

15.7.7.2.2.3.1.  Sequence- and ligation -Independent Cloning (SLIC)

15.7.7.2.2.3.2.  Transformation-associated Recombination

15.7.7.2.2.3.3.  BioBrick Assembly

15.7.7.3.  Southeast Asia Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Components

15.7.7.3.1.  Software

15.7.7.3.2.  Services

15.7.7.4.  Southeast Asia Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Application

15.7.7.4.1.  Research and Development

15.7.7.4.2.  Diagnosis

15.7.7.4.3.  Therapeutics

15.7.7.4.4.  Other applications

15.7.7.5.  Southeast Asia Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By End User

15.7.7.5.1.  Biotech and Pharmaceuticals Companies

15.7.7.5.2.  Academic and Research Institutes

15.7.7.5.3.  Contract Research Organizations

15.7.7.6.  Southeast Asia Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Country

15.7.7.6.1.  Indonesia

15.7.7.6.2.  Thailand

15.7.7.6.3.  Malaysia

15.7.7.6.4.  Singapore

15.7.7.6.5.  Rest of South Asia

15.7.8. Rest of Asia Pacific

15.7.8.1.  Rest of Asia Pacific Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Type

15.7.8.1.1.  Custom Gene Synthesis

15.7.8.1.1.1. cDNA

15.7.8.1.1.2. Customized Coding Sequences

15.7.8.1.1.3. Genomic DNA

15.7.8.1.1.4. RNAi constructs (shRNA, siRNA, miRNA)

15.7.8.1.1.5. Others

15.7.8.1.2.  Gene Library Synthesis

15.7.8.2.  Rest of Asia Pacific Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Method

15.7.8.2.1.  Oligo Synthesis

15.7.8.2.1.1. Phosphoramidite Reaction Cycle

15.7.8.2.1.2. High-throughput Array-Based Gene Synthesis Technology

15.7.8.2.2.  Gene assembly

15.7.8.2.2.1. Polymerase-Based

15.7.8.2.2.1.1.  Dual-Asymmetric (DA) PCR

15.7.8.2.2.1.2.  Overlap Extension (OE)

15.7.8.2.2.1.3.  Polymerase Cycling Assembly

15.7.8.2.2.1.4.  Thermodynamically-Balanced Inside-Out (TBIO)

15.7.8.2.2.1.5.  Microchip-based multiplex gene synthesis

15.7.8.2.2.1.6.  Others

15.7.8.2.2.2. Ligase- Based

15.7.8.2.2.2.1.  Shotgun Ligation

15.7.8.2.2.2.2.  Two-Step Ligation and PCR

15.7.8.2.2.2.3.  Ligase Chain Reaction

15.7.8.2.2.2.4.  Brick-Based

15.7.8.2.2.3. Recombination-Based

15.7.8.2.2.3.1.  Sequence- and ligation -Independent Cloning (SLIC)

15.7.8.2.2.3.2.  Transformation-associated Recombination

15.7.8.2.2.3.3.  BioBrick Assembly

15.7.8.3.  Rest of Asia Pacific Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Components

15.7.8.3.1.  Software

15.7.8.3.2.  Services

15.7.8.4.  Rest of Asia Pacific Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Application

15.7.8.4.1.  Research and Development

15.7.8.4.2.  Diagnosis

15.7.8.4.3.  Therapeutics

15.7.8.4.4.  Other applications

15.7.8.5.  Rest of Asia Pacific Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By End User

15.7.8.5.1.  Biotech and Pharmaceuticals Companies

15.7.8.5.2.  Academic and Research Institutes

15.7.8.5.3.  Contract Research Organizations

15.8. Key Segment for Channeling Investments

15.8.1. By Country

15.8.2. By Type

15.8.3. By Method

15.8.4. By Components

15.8.5. By Application

15.8.6. By End User

16. Middle East and Africa Gene Synthesis Market Analysis and Forecasts, 2019 - 2027

16.1. Overview

16.1.1. Middle East and Africa Gene Synthesis Market Revenue (US$ Mn)

16.2. Middle East and Africa Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Type

16.2.1. Custom Gene Synthesis

16.2.1.1.  cDNA

16.2.1.2.  Customized Coding Sequences

16.2.1.3.  Genomic DNA

16.2.1.4.  RNAi constructs (shRNA, siRNA, miRNA)

16.2.1.5.  Others

16.2.2. Gene Library Synthesis

16.3. Middle East and Africa Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Method

16.3.1. Oligo Synthesis

16.3.1.1.  Phosphoramidite Reaction Cycle

16.3.1.2.  High-throughput Array-Based Gene Synthesis Technology

16.3.2. Gene assembly

16.3.2.1.  Polymerase-Based

16.3.2.1.1.  Dual-Asymmetric (DA) PCR

16.3.2.1.2.  Overlap Extension (OE)

16.3.2.1.3.  Polymerase Cycling Assembly

16.3.2.1.4.  Thermodynamically-Balanced Inside-Out (TBIO)

16.3.2.1.5.  Microchip-based multiplex gene synthesis

16.3.2.1.6.  Others

16.3.2.2.  Ligase- Based

16.3.2.2.1.  Shotgun Ligation

16.3.2.2.2.  Two-Step Ligation and PCR

16.3.2.2.3.  Ligase Chain Reaction

16.3.2.2.4.  Brick-Based

16.3.2.3.  Recombination-Based

16.3.2.3.1.  Sequence- and ligation -Independent Cloning (SLIC)

16.3.2.3.2.  Transformation-associated Recombination

16.3.2.3.3.  BioBrick Assembly

16.4. Middle East and Africa Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Components

16.4.1. Software

16.4.2. Services

16.5. Middle East and Africa Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Application

16.5.1. Research and Development

16.5.2. Diagnosis

16.5.3. Therapeutics

16.5.4. Other applications

16.6. Middle East and Africa Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By End User

16.6.1. Biotech and Pharmaceuticals Companies

16.6.2. Academic and Research Institutes

16.6.3. Contract Research Organizations

16.7. Middle East and Africa Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Country

16.7.1. Saudi Arabia

16.7.1.1.  Saudi Arabia Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Type

16.7.1.1.1.  Custom Gene Synthesis

16.7.1.1.1.1. cDNA

16.7.1.1.1.2. Customized Coding Sequences

16.7.1.1.1.3. Genomic DNA

16.7.1.1.1.4. RNAi constructs (shRNA, siRNA, miRNA)

16.7.1.1.1.5. Others

16.7.1.1.2.  Gene Library Synthesis

16.7.1.2.  Saudi Arabia Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Method

16.7.1.2.1.  Oligo Synthesis

16.7.1.2.1.1. Phosphoramidite Reaction Cycle

16.7.1.2.1.2. High-throughput Array-Based Gene Synthesis Technology

16.7.1.2.2.  Gene assembly

16.7.1.2.2.1. Polymerase-Based

16.7.1.2.2.1.1.  Dual-Asymmetric (DA) PCR

16.7.1.2.2.1.2.  Overlap Extension (OE)

16.7.1.2.2.1.3.  Polymerase Cycling Assembly

16.7.1.2.2.1.4.  Thermodynamically-Balanced Inside-Out (TBIO)

16.7.1.2.2.1.5.  Microchip-based multiplex gene synthesis

16.7.1.2.2.1.6.  Others

16.7.1.2.2.2. Ligase- Based

16.7.1.2.2.2.1.  Shotgun Ligation

16.7.1.2.2.2.2.  Two-Step Ligation and PCR

16.7.1.2.2.2.3.  Ligase Chain Reaction

16.7.1.2.2.2.4.  Brick-Based

16.7.1.2.2.3. Recombination-Based

16.7.1.2.2.3.1.  Sequence- and ligation -Independent Cloning (SLIC)

16.7.1.2.2.3.2.  Transformation-associated Recombination

16.7.1.2.2.3.3.  BioBrick Assembly

16.7.1.3.  Saudi Arabia Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Components

16.7.1.3.1.  Software

16.7.1.3.2.  Services

16.7.1.4.  Saudi Arabia Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Application

16.7.1.4.1.  Research and Development

16.7.1.4.2.  Diagnosis

16.7.1.4.3.  Therapeutics

16.7.1.4.4.  Other applications

16.7.1.5.  Saudi Arabia Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By End User

16.7.1.5.1.  Biotech and Pharmaceuticals Companies

16.7.1.5.2.  Academic and Research Institutes

16.7.1.5.3.  Contract Research Organizations

16.7.2. UAE

16.7.2.1.  UAE Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Type

16.7.2.1.1.  Custom Gene Synthesis

16.7.2.1.1.1. cDNA

16.7.2.1.1.2. Customized Coding Sequences

16.7.2.1.1.3. Genomic DNA

16.7.2.1.1.4. RNAi constructs (shRNA, siRNA, miRNA)

16.7.2.1.1.5. Others

16.7.2.1.2.  Gene Library Synthesis

16.7.2.2.  UAE Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Method

16.7.2.2.1.  Oligo Synthesis

16.7.2.2.1.1. Phosphoramidite Reaction Cycle

16.7.2.2.1.2. High-throughput Array-Based Gene Synthesis Technology

16.7.2.2.2.  Gene assembly

16.7.2.2.2.1. Polymerase-Based

16.7.2.2.2.1.1.  Dual-Asymmetric (DA) PCR

16.7.2.2.2.1.2.  Overlap Extension (OE)

16.7.2.2.2.1.3.  Polymerase Cycling Assembly

16.7.2.2.2.1.4.  Thermodynamically-Balanced Inside-Out (TBIO)

16.7.2.2.2.1.5.  Microchip-based multiplex gene synthesis

16.7.2.2.2.1.6.  Others

16.7.2.2.2.2. Ligase- Based

16.7.2.2.2.2.1.  Shotgun Ligation

16.7.2.2.2.2.2.  Two-Step Ligation and PCR

16.7.2.2.2.2.3.  Ligase Chain Reaction

16.7.2.2.2.2.4.  Brick-Based

16.7.2.2.2.3. Recombination-Based

16.7.2.2.2.3.1.  Sequence- and ligation -Independent Cloning (SLIC)

16.7.2.2.2.3.2.  Transformation-associated Recombination

16.7.2.2.2.3.3.  BioBrick Assembly

16.7.2.3.  UAE Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Components

16.7.2.3.1.  Software

16.7.2.3.2.  Services

16.7.2.4.  UAE Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Application

16.7.2.4.1.  Research and Development

16.7.2.4.2.  Diagnosis

16.7.2.4.3.  Therapeutics

16.7.2.4.4.  Other applications

16.7.2.5.  UAE Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By End User

16.7.2.5.1.  Biotech and Pharmaceuticals Companies

16.7.2.5.2.  Academic and Research Institutes

16.7.2.5.3.  Contract Research Organizations

16.7.3. Egypt

16.7.3.1.  Egypt Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Type

16.7.3.1.1.  Custom Gene Synthesis

16.7.3.1.1.1. cDNA

16.7.3.1.1.2. Customized Coding Sequences

16.7.3.1.1.3. Genomic DNA

16.7.3.1.1.4. RNAi constructs (shRNA, siRNA, miRNA)

16.7.3.1.1.5. Others

16.7.3.1.2.  Gene Library Synthesis

16.7.3.2.  Egypt Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Method

16.7.3.2.1.  Oligo Synthesis

16.7.3.2.1.1. Phosphoramidite Reaction Cycle

16.7.3.2.1.2. High-throughput Array-Based Gene Synthesis Technology

16.7.3.2.2.  Gene assembly

16.7.3.2.2.1. Polymerase-Based

16.7.3.2.2.1.1.  Dual-Asymmetric (DA) PCR

16.7.3.2.2.1.2.  Overlap Extension (OE)

16.7.3.2.2.1.3.  Polymerase Cycling Assembly

16.7.3.2.2.1.4.  Thermodynamically-Balanced Inside-Out (TBIO)

16.7.3.2.2.1.5.  Microchip-based multiplex gene synthesis

16.7.3.2.2.1.6.  Others

16.7.3.2.2.2. Ligase- Based

16.7.3.2.2.2.1.  Shotgun Ligation

16.7.3.2.2.2.2.  Two-Step Ligation and PCR

16.7.3.2.2.2.3.  Ligase Chain Reaction

16.7.3.2.2.2.4.  Brick-Based

16.7.3.2.2.3. Recombination-Based

16.7.3.2.2.3.1.  Sequence- and ligation -Independent Cloning (SLIC)

16.7.3.2.2.3.2.  Transformation-associated Recombination

16.7.3.2.2.3.3.  BioBrick Assembly

16.7.3.3.  Egypt Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Components

16.7.3.3.1.  Software

16.7.3.3.2.  Services

16.7.3.4.  Egypt Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Application

16.7.3.4.1.  Research and Development

16.7.3.4.2.  Diagnosis

16.7.3.4.3.  Therapeutics

16.7.3.4.4.  Other applications

16.7.3.5.  Egypt Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By End User

16.7.3.5.1.  Biotech and Pharmaceuticals Companies

16.7.3.5.2.  Academic and Research Institutes

16.7.3.5.3.  Contract Research Organizations

16.7.4. Kuwait

16.7.4.1.  Kuwait Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Type

16.7.4.1.1.  Custom Gene Synthesis

16.7.4.1.1.1. cDNA

16.7.4.1.1.2. Customized Coding Sequences

16.7.4.1.1.3. Genomic DNA

16.7.4.1.1.4. RNAi constructs (shRNA, siRNA, miRNA)

16.7.4.1.1.5. Others

16.7.4.1.2.  Gene Library Synthesis

16.7.4.2.  Kuwait Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Method

16.7.4.2.1.  Oligo Synthesis

16.7.4.2.1.1. Phosphoramidite Reaction Cycle

16.7.4.2.1.2. High-throughput Array-Based Gene Synthesis Technology

16.7.4.2.2.  Gene assembly

16.7.4.2.2.1. Polymerase-Based

16.7.4.2.2.1.1.  Dual-Asymmetric (DA) PCR

16.7.4.2.2.1.2.  Overlap Extension (OE)

16.7.4.2.2.1.3.  Polymerase Cycling Assembly

16.7.4.2.2.1.4.  Thermodynamically-Balanced Inside-Out (TBIO)

16.7.4.2.2.1.5.  Microchip-based multiplex gene synthesis

16.7.4.2.2.1.6.  Others

16.7.4.2.2.2. Ligase- Based

16.7.4.2.2.2.1.  Shotgun Ligation

16.7.4.2.2.2.2.  Two-Step Ligation and PCR

16.7.4.2.2.2.3.  Ligase Chain Reaction

16.7.4.2.2.2.4.  Brick-Based

16.7.4.2.2.3. Recombination-Based

16.7.4.2.2.3.1.  Sequence- and ligation -Independent Cloning (SLIC)

16.7.4.2.2.3.2.  Transformation-associated Recombination

16.7.4.2.2.3.3.  BioBrick Assembly

16.7.4.3.  Kuwait Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Components

16.7.4.3.1.  Software

16.7.4.3.2.  Services

16.7.4.4.  Kuwait Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Application

16.7.4.4.1.  Research and Development

16.7.4.4.2.  Diagnosis

16.7.4.4.3.  Therapeutics

16.7.4.4.4.  Other applications

16.7.4.5.  Kuwait Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By End User

16.7.4.5.1.  Biotech and Pharmaceuticals Companies

16.7.4.5.2.  Academic and Research Institutes

16.7.4.5.3.  Contract Research Organizations

16.7.5. South Africa

16.7.5.1.  South Africa Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Type

16.7.5.1.1.  Custom Gene Synthesis

16.7.5.1.1.1. cDNA

16.7.5.1.1.2. Customized Coding Sequences

16.7.5.1.1.3. Genomic DNA

16.7.5.1.1.4. RNAi constructs (shRNA, siRNA, miRNA)

16.7.5.1.1.5. Others

16.7.5.1.2.  Gene Library Synthesis

16.7.5.2.  South Africa Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Method

16.7.5.2.1.  Oligo Synthesis

16.7.5.2.1.1. Phosphoramidite Reaction Cycle

16.7.5.2.1.2. High-throughput Array-Based Gene Synthesis Technology

16.7.5.2.2.  Gene assembly

16.7.5.2.2.1. Polymerase-Based

16.7.5.2.2.1.1.  Dual-Asymmetric (DA) PCR

16.7.5.2.2.1.2.  Overlap Extension (OE)

16.7.5.2.2.1.3.  Polymerase Cycling Assembly

16.7.5.2.2.1.4.  Thermodynamically-Balanced Inside-Out (TBIO)

16.7.5.2.2.1.5.  Microchip-based multiplex gene synthesis

16.7.5.2.2.1.6.  Others

16.7.5.2.2.2. Ligase- Based

16.7.5.2.2.2.1.  Shotgun Ligation

16.7.5.2.2.2.2.  Two-Step Ligation and PCR

16.7.5.2.2.2.3.  Ligase Chain Reaction

16.7.5.2.2.2.4.  Brick-Based

16.7.5.2.2.3. Recombination-Based

16.7.5.2.2.3.1.  Sequence- and ligation -Independent Cloning (SLIC)

16.7.5.2.2.3.2.  Transformation-associated Recombination

16.7.5.2.2.3.3.  BioBrick Assembly

16.7.5.3.  South Africa Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Components

16.7.5.3.1.  Software

16.7.5.3.2.  Services

16.7.5.4.  South Africa Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Application

16.7.5.4.1.  Research and Development

16.7.5.4.2.  Diagnosis

16.7.5.4.3.  Therapeutics

16.7.5.4.4.  Other applications

16.7.5.5.  South Africa Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By End User

16.7.5.5.1.  Biotech and Pharmaceuticals Companies

16.7.5.5.2.  Academic and Research Institutes

16.7.5.5.3.  Contract Research Organizations

16.7.6. Rest of Middle East & Africa

16.7.6.1.  Rest of Middle East & Africa Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Type

16.7.6.1.1.  Custom Gene Synthesis

16.7.6.1.1.1. cDNA

16.7.6.1.1.2. Customized Coding Sequences

16.7.6.1.1.3. Genomic DNA

16.7.6.1.1.4. RNAi constructs (shRNA, siRNA, miRNA)

16.7.6.1.1.5. Others

16.7.6.1.2.  Gene Library Synthesis

16.7.6.2.  Rest of Middle East & Africa Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Method

16.7.6.2.1.  Oligo Synthesis

16.7.6.2.1.1. Phosphoramidite Reaction Cycle

16.7.6.2.1.2. High-throughput Array-Based Gene Synthesis Technology

16.7.6.2.2.  Gene assembly

16.7.6.2.2.1. Polymerase-Based

16.7.6.2.2.1.1.  Dual-Asymmetric (DA) PCR

16.7.6.2.2.1.2.  Overlap Extension (OE)

16.7.6.2.2.1.3.  Polymerase Cycling Assembly

16.7.6.2.2.1.4.  Thermodynamically-Balanced Inside-Out (TBIO)

16.7.6.2.2.1.5.  Microchip-based multiplex gene synthesis

16.7.6.2.2.1.6.  Others

16.7.6.2.2.2. Ligase- Based

16.7.6.2.2.2.1.  Shotgun Ligation

16.7.6.2.2.2.2.  Two-Step Ligation and PCR

16.7.6.2.2.2.3.  Ligase Chain Reaction

16.7.6.2.2.2.4.  Brick-Based

16.7.6.2.2.3. Recombination-Based

16.7.6.2.2.3.1.  Sequence- and ligation -Independent Cloning (SLIC)

16.7.6.2.2.3.2.  Transformation-associated Recombination

16.7.6.2.2.3.3.  BioBrick Assembly

16.7.6.3.  Rest of Middle East & Africa Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Components

16.7.6.3.1.  Software

16.7.6.3.2.  Services

16.7.6.4.  Rest of Middle East & Africa Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Application

16.7.6.4.1.  Research and Development

16.7.6.4.2.  Diagnosis

16.7.6.4.3.  Therapeutics

16.7.6.4.4.  Other applications

16.7.6.5.  Rest of Middle East & Africa Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By End User

16.7.6.5.1.  Biotech and Pharmaceuticals Companies

16.7.6.5.2.  Academic and Research Institutes

16.7.6.5.3.  Contract Research Organizations

16.8. Key Segment for Channeling Investments

16.8.1. By Country

16.8.2. By Type

16.8.3. By Method

16.8.4. By Components

16.8.5. By Application

16.8.6. By End User

17. Latin America Gene Synthesis Market Analysis and Forecasts, 2019 - 2027

17.1. Overview

17.1.1. Latin America Gene Synthesis Market Revenue (US$ Mn)

17.2. Latin America Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Type

17.2.1. Custom Gene Synthesis

17.2.1.1.  cDNA

17.2.1.2.  Customized Coding Sequences

17.2.1.3.  Genomic DNA

17.2.1.4.  RNAi constructs (shRNA, siRNA, miRNA)

17.2.1.5.  Others

17.2.2. Gene Library Synthesis

17.3. Latin America Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Method

17.3.1. Oligo Synthesis

17.3.1.1.  Phosphoramidite Reaction Cycle

17.3.1.2.  High-throughput Array-Based Gene Synthesis Technology

17.3.2. Gene assembly

17.3.2.1.  Polymerase-Based

17.3.2.1.1.  Dual-Asymmetric (DA) PCR

17.3.2.1.2.  Overlap Extension (OE)

17.3.2.1.3.  Polymerase Cycling Assembly

17.3.2.1.4.  Thermodynamically-Balanced Inside-Out (TBIO)

17.3.2.1.5.  Microchip-based multiplex gene synthesis

17.3.2.1.6.  Others

17.3.2.2.  Ligase- Based

17.3.2.2.1.  Shotgun Ligation

17.3.2.2.2.  Two-Step Ligation and PCR

17.3.2.2.3.  Ligase Chain Reaction

17.3.2.2.4.  Brick-Based

17.3.2.3.  Recombination-Based

17.3.2.3.1.  Sequence- and ligation -Independent Cloning (SLIC)

17.3.2.3.2.  Transformation-associated Recombination

17.3.2.3.3.  BioBrick Assembly

17.4. Latin America Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Components

17.4.1. Software

17.4.2. Services

17.5. Latin America Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Application

17.5.1. Research and Development

17.5.2. Diagnosis

17.5.3. Therapeutics

17.5.4. Other applications

17.6. Latin America Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By End User

17.6.1. Biotech and Pharmaceuticals Companies

17.6.2. Academic and Research Institutes

17.6.3. Contract Research Organizations

17.7. Latin America Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Country

17.7.1. Brazil

17.7.1.1.  Brazil Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Type

17.7.1.1.1.  Custom Gene Synthesis

17.7.1.1.1.1. cDNA

17.7.1.1.1.2. Customized Coding Sequences

17.7.1.1.1.3. Genomic DNA

17.7.1.1.1.4. RNAi constructs (shRNA, siRNA, miRNA)

17.7.1.1.1.5. Others

17.7.1.1.2.  Gene Library Synthesis

17.7.1.2.  Brazil Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Method

17.7.1.2.1.  Oligo Synthesis

17.7.1.2.1.1. Phosphoramidite Reaction Cycle

17.7.1.2.1.2. High-throughput Array-Based Gene Synthesis Technology

17.7.1.2.2.  Gene assembly

17.7.1.2.2.1. Polymerase-Based

17.7.1.2.2.1.1.  Dual-Asymmetric (DA) PCR

17.7.1.2.2.1.2.  Overlap Extension (OE)

17.7.1.2.2.1.3.  Polymerase Cycling Assembly

17.7.1.2.2.1.4.  Thermodynamically-Balanced Inside-Out (TBIO)

17.7.1.2.2.1.5.  Microchip-based multiplex gene synthesis

17.7.1.2.2.1.6.  Others

17.7.1.2.2.2. Ligase- Based

17.7.1.2.2.2.1.  Shotgun Ligation

17.7.1.2.2.2.2.  Two-Step Ligation and PCR

17.7.1.2.2.2.3.  Ligase Chain Reaction

17.7.1.2.2.2.4.  Brick-Based

17.7.1.2.2.3. Recombination-Based

17.7.1.2.2.3.1.  Sequence- and ligation -Independent Cloning (SLIC)

17.7.1.2.2.3.2.  Transformation-associated Recombination

17.7.1.2.2.3.3.  BioBrick Assembly

17.7.1.3.  Brazil Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Components

17.7.1.3.1.  Software

17.7.1.3.2.  Services

17.7.1.4.  Brazil Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Application

17.7.1.4.1.  Research and Development

17.7.1.4.2.  Diagnosis

17.7.1.4.3.  Therapeutics

17.7.1.4.4.  Other applications

17.7.1.5.  Brazil Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By End User

17.7.1.5.1.  Biotech and Pharmaceuticals Companies

17.7.1.5.2.  Academic and Research Institutes

17.7.1.5.3.  Contract Research Organizations

17.7.2. Argentina

17.7.2.1.  Argentina Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Type

17.7.2.1.1.  Custom Gene Synthesis

17.7.2.1.1.1. cDNA

17.7.2.1.1.2. Customized Coding Sequences

17.7.2.1.1.3. Genomic DNA

17.7.2.1.1.4. RNAi constructs (shRNA, siRNA, miRNA)

17.7.2.1.1.5. Others

17.7.2.1.2.  Gene Library Synthesis

17.7.2.2.  Argentina Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Method

17.7.2.2.1.  Oligo Synthesis

17.7.2.2.1.1. Phosphoramidite Reaction Cycle

17.7.2.2.1.2. High-throughput Array-Based Gene Synthesis Technology

17.7.2.2.2.  Gene assembly

17.7.2.2.2.1. Polymerase-Based

17.7.2.2.2.1.1.  Dual-Asymmetric (DA) PCR

17.7.2.2.2.1.2.  Overlap Extension (OE)

17.7.2.2.2.1.3.  Polymerase Cycling Assembly

17.7.2.2.2.1.4.  Thermodynamically-Balanced Inside-Out (TBIO)

17.7.2.2.2.1.5.  Microchip-based multiplex gene synthesis

17.7.2.2.2.1.6.  Others

17.7.2.2.2.2. Ligase- Based

17.7.2.2.2.2.1.  Shotgun Ligation

17.7.2.2.2.2.2.  Two-Step Ligation and PCR

17.7.2.2.2.2.3.  Ligase Chain Reaction

17.7.2.2.2.2.4.  Brick-Based

17.7.2.2.2.3. Recombination-Based

17.7.2.2.2.3.1.  Sequence- and ligation -Independent Cloning (SLIC)

17.7.2.2.2.3.2.  Transformation-associated Recombination

17.7.2.2.2.3.3.  BioBrick Assembly

17.7.2.3.  Argentina Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Components

17.7.2.3.1.  Software

17.7.2.3.2.  Services

17.7.2.4.  Argentina Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Application

17.7.2.4.1.  Research and Development

17.7.2.4.2.  Diagnosis

17.7.2.4.3.  Therapeutics

17.7.2.4.4.  Other applications

17.7.2.5.  Argentina Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By End User

17.7.2.5.1.  Biotech and Pharmaceuticals Companies

17.7.2.5.2.  Academic and Research Institutes

17.7.2.5.3.  Contract Research Organizations

17.7.3. Rest of Latin America

17.7.3.1.  Rest of Latin America Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Type

17.7.3.1.1.  Custom Gene Synthesis

17.7.3.1.1.1. cDNA

17.7.3.1.1.2. Customized Coding Sequences

17.7.3.1.1.3. Genomic DNA

17.7.3.1.1.4. RNAi constructs (shRNA, siRNA, miRNA)

17.7.3.1.1.5. Others

17.7.3.1.2.  Gene Library Synthesis

17.7.3.2.  Rest of Latin America Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Method

17.7.3.2.1.  Oligo Synthesis

17.7.3.2.1.1. Phosphoramidite Reaction Cycle

17.7.3.2.1.2. High-throughput Array-Based Gene Synthesis Technology

17.7.3.2.2.  Gene assembly

17.7.3.2.2.1. Polymerase-Based

17.7.3.2.2.1.1.  Dual-Asymmetric (DA) PCR

17.7.3.2.2.1.2.  Overlap Extension (OE)

17.7.3.2.2.1.3.  Polymerase Cycling Assembly

17.7.3.2.2.1.4.  Thermodynamically-Balanced Inside-Out (TBIO)

17.7.3.2.2.1.5.  Microchip-based multiplex gene synthesis

17.7.3.2.2.1.6.  Others

17.7.3.2.2.2. Ligase- Based

17.7.3.2.2.2.1.  Shotgun Ligation

17.7.3.2.2.2.2.  Two-Step Ligation and PCR

17.7.3.2.2.2.3.  Ligase Chain Reaction

17.7.3.2.2.2.4.  Brick-Based

17.7.3.2.2.3. Recombination-Based

17.7.3.2.2.3.1.  Sequence- and ligation -Independent Cloning (SLIC)

17.7.3.2.2.3.2.  Transformation-associated Recombination

17.7.3.2.2.3.3.  BioBrick Assembly

17.7.3.3.  Rest of Latin America Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Components

17.7.3.3.1.  Software

17.7.3.3.2.  Services

17.7.3.4.  Rest of Latin America Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By Application

17.7.3.4.1.  Research and Development

17.7.3.4.2.  Diagnosis

17.7.3.4.3.  Therapeutics

17.7.3.4.4.  Other applications

17.7.3.5.  Rest of Latin America Gene Synthesis Market Revenue (US$ Mn) and Forecasts, By End User

17.7.3.5.1.  Biotech and Pharmaceuticals Companies

17.7.3.5.2.  Academic and Research Institutes

17.7.3.5.3.  Contract Research Organizations

17.8. Key Segment for Channeling Investments

17.8.1. By Country

17.8.2. By Type

17.8.3. By Method

17.8.4. By Components

17.8.5. By Application

17.8.6. By End User

18. Competitive Benchmarking

18.1. Brand Benchmarking

18.2. Market Share Analysis, 2018

18.3. Global Presence and Growth Strategies

18.3.1. Mergers and Acquisitions

18.3.2. Product Launches

18.3.3. Investments Trends

18.3.4. R&D Initiatives

19. Player Profiles

19.1. ATDBio Ltd

19.1.1. Company Details

19.1.2. Company Overview

19.1.3. Product Offerings

19.1.4. Key Developments

19.1.5. Financial Analysis

19.1.6. SWOT Analysis

19.1.7. Business Strategies

19.2. ATUM

19.2.1. Company Details

19.2.2. Company Overview

19.2.3. Product Offerings

19.2.4. Key Developments

19.2.5. Financial Analysis

19.2.6. SWOT Analysis

19.2.7. Business Strategies

19.3. BioCat GmbH

19.3.1. Company Details

19.3.2. Company Overview

19.3.3. Product Offerings

19.3.4. Key Developments

19.3.5. Financial Analysis

19.3.6. SWOT Analysis

19.3.7. Business Strategies

19.4. Biomatik

19.4.1. Company Details

19.4.2. Company Overview

19.4.3. Product Offerings

19.4.4. Key Developments

19.4.5. Financial Analysis

19.4.6. SWOT Analysis

19.4.7. Business Strategies

19.5. BIONEER CORPORATION

19.5.1. Company Details

19.5.2. Company Overview

19.5.3. Product Offerings

19.5.4. Key Developments

19.5.5. Financial Analysis

19.5.6. SWOT Analysis

19.5.7. Business Strategies

19.6. Blue Heron Biotech, LLC

19.6.1. Company Details

19.6.2. Company Overview

19.6.3. Product Offerings

19.6.4. Key Developments

19.6.5. Financial Analysis

19.6.6. SWOT Analysis

19.6.7. Business Strategies

19.7. Epoch Life Science Inc

19.7.1. Company Details

19.7.2. Company Overview

19.7.3. Product Offerings

19.7.4. Key Developments

19.7.5. Financial Analysis

19.7.6. SWOT Analysis

19.7.7. Business Strategies

19.8. Eurofins Genomics LLC

19.8.1. Company Details

19.8.2. Company Overview

19.8.3. Product Offerings

19.8.4. Key Developments

19.8.5. Financial Analysis

19.8.6. SWOT Analysis

19.8.7. Business Strategies

19.9. GENEWIZ

19.9.1. Company Details

19.9.2. Company Overview

19.9.3. Product Offerings

19.9.4. Key Developments

19.9.5. Financial Analysis

19.9.6. SWOT Analysis

19.9.7. Business Strategies

19.10. Genscript

19.10.1. Company Details

19.10.2. Company Overview

19.10.3. Product Offerings

19.10.4. Key Developments

19.10.5. Financial Analysis

19.10.6. SWOT Analysis

19.10.7. Business Strategies

19.11. Integrated DNA Technologies, Inc

19.11.1. Company Details

19.11.2. Company Overview

19.11.3. Product Offerings

19.11.4. Key Developments

19.11.5. Financial Analysis

19.11.6. SWOT Analysis

19.11.7. Business Strategies

19.12. Kaneka Eurogentec S.A.

19.12.1. Company Details

19.12.2. Company Overview

19.12.3. Product Offerings

19.12.4. Key Developments

19.12.5. Financial Analysis

19.12.6. SWOT Analysis

19.12.7. Business Strategies

19.13. OriGene Technologies, Inc.

19.13.1. Company Details

19.13.2. Company Overview

19.13.3. Product Offerings

19.13.4. Key Developments

19.13.5. Financial Analysis

19.13.6. SWOT Analysis

19.13.7. Business Strategies

19.14. ProteoGenix

19.14.1. Company Details

19.14.2. Company Overview

19.14.3. Product Offerings

19.14.4. Key Developments

19.14.5. Financial Analysis

19.14.6. SWOT Analysis

19.14.7. Business Strategies

19.15. Shanghai Medicilon inc.

19.15.1. Company Details

19.15.2. Company Overview

19.15.3. Product Offerings

19.15.4. Key Developments

19.15.5. Financial Analysis

19.15.6. SWOT Analysis

19.15.7. Business Strategies

19.16. Synbio Technologies LLC

19.16.1. Company Details

19.16.2. Company Overview

19.16.3. Product Offerings

19.16.4. Key Developments

19.16.5. Financial Analysis

19.16.6. SWOT Analysis

19.16.7. Business Strategies

19.17. Thermo Fisher Scientific Inc

19.17.1. Company Details

19.17.2. Company Overview

19.17.3. Product Offerings

19.17.4. Key Developments

19.17.5. Financial Analysis

19.17.6. SWOT Analysis

19.17.7. Business Strategies

19.18. Vigene Biosciences Inc.

19.18.1. Company Details

19.18.2. Company Overview

19.18.3. Product Offerings

19.18.4. Key Developments

19.18.5. Financial Analysis

19.18.6. SWOT Analysis

19.18.7. Business Strategies

20. Key Findings

 

Note: This ToC is tentative and can be changed according to the research study conducted during the course of report completion.

 

**Exclusive for Multi-User and Enterprise User.

At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.

Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews  are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.  

Prominent participants in our primary research process include:

  • Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
  • Research and development participants, distributors/suppliers and subject matter experts

Secondary Research includes data extracted from paid data sources:

  • Reuters
  • Factiva
  • Bloomberg
  • One Source
  • Hoovers

Research Methodology

Methodology

Key Inclusions

Methodology

  • A PHP Error was encountered

    Severity: Notice

    Message: Undefined offset: 0

    Filename: pages/reportpage.php

    Line Number: 163

    Backtrace:

    File: /var/www/html/ami/application/views/pages/reportpage.php
    Line: 163
    Function: _error_handler

    File: /var/www/html/ami/application/controllers/Report.php
    Line: 153
    Function: view

    File: /var/www/html/ami/index.php
    Line: 315
    Function: require_once